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Investing in health and health systems is especially important during 
times of crisis, such as the severe economic crisis and pandemic (H1N1) 
2009 influenza. To address these issues, governments and policy-makers 
need information that is current, accurate, comparable and user-friendly. 
What were the trends in public health indicators over the last four 
years? What faactors influence health, and what are the challenges for 
the future? What contribution can health systems make to improve 
population health in the WHO European Region? In addressing these 
questions, this report illustrates the wide-ranging reforms countries have 
undertaken to strengthen performance in four core functions of health 
systems: service delivery, resource generation, financing and stewardship. 
This report presents essential public health information to support 
countries in choosing sound investments in health. It should encourage 
the successful implementation of effective health system reforms and 
policies, and help countries improve their health systems’ performance 
to provide efficient, patient-centred, high-quality health care. The annex 
provides some of the data used in the analysis.
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Foreword  
As part of its mandate to monitor and report on the health of nearly 900 million people in the WHO 
European Region, the WHO Regional Office for Europe issues this report as its flagship 
publication, every three years. In the 2009 European health report focused on the role of health 
systems in contributing to health, approaches to strengthen health systems’ functions based on cost-
effective interventions and performance assessment, and referred to the 2008 Tallinn Charter: 
Health Systems for Health and Wealth. The 2012 European health report focuses on supporting and 
providing the evidence base for the strategic objectives and priorities of Health 2020, the new 
European policy framework to support action across government and society for health and well-
being, endorsed in 2012 by European Member States. 
This new European policy is the beginning of a new united fight to save not just the lives of the 
citizens of today’s Europe but also those of generations to come. It targets the main health 
challenges in the 53 countries in the Region, such as increasing health inequities within and 
between countries, shrinking public service expenditure due to the financial crisis, and a growing 
burden of ill health from noncommunicable diseases such as obesity, cancer and heart disease. Its 
implementation will help to mobilize decision-makers everywhere, within and beyond the 
boundaries of the health sector. Given that so many factors affect health and that health affects so 
many areas of human life, progress on public health can only come from whole-of-society and 
whole-of-government efforts. This is why everyone has a role to play in implementing Health 2020, 
from prime ministers to civil-society organizations to citizens. It is also why this work requires 
increasing attention to and understanding of health and well-being, in addition to reducing 
morbidity and mortality and improving health systems’ performance through such means as 
reaching universal coverage. 
The timing of this report thus offers an excellent opportunity to provide policy-makers and public 
health professionals with the epidemiological evidence base underpinning Health 2020 and to 
outline the tools and methods to measure progress. The report also provides insight into one of the 
pivotal aspects of Health 2020: well-being as a marker of progress in health in the Region. Well-
being stands at the centre of the WHO Constitution’s definition of health: “not merely the absence 
of disease or infirmity” but “a state of complete physical, mental and social well-being”. 
This report presents the current epidemiological profile of the Region’s 53 Member States and the 
agreed approach to monitoring progress towards Health 2020, specifically through a small set of 
agreed European goals (overarching targets) and proposed indicators to be further refined. The 
 ix 
 
report also identifies important challenges to measuring progress towards Health 2020 and 
outlines a collaborative agenda to address them, with the WHO Regional Office for Europe as a 
facilitator and convener, working with European institutions and partnering Member States. 
This report is written for policy-makers in European countries and all public health professionals 
concerned with the implementation of the new policy. It should also interest academic institutions, 
nongovernmental organizations and other groups keen to contribute to Health 2020, strengthen 
solidarity across Europe and reduce inequalities within and across countries in the European 
Region. 
The report describes how the Region’s 53 Member States came to agree on the set of overarching 
targets, which are expressed as European averages. This follows a European tradition first put into 
practice through the Health for All policy and continued in HEALTH21 two decades later. The report 
describes in detail the methods and baseline for target setting at the European level, as progress on 
the overarching targets will be reported at this level. Nevertheless, most actions will occur at the 
country level, so these details can also inspire countries to set or reset their own targets for health, 
reflecting their particular circumstances and starting points. 
My team at the Regional Office and I are committed to reporting regularly on the progress towards 
the European goals for health and well-being and on our efforts to overcome measurement 
challenges. We will conduct annual analyses and mark progress with our first set of milestones in 
2015. I am sure that the commitment of all 53 Member States to the implementation of Health 2020 
will be a strong catalyst for success in Europe in the years 
to come. 
Zsuzsanna Jakab 
WHO Regional Director for Europe 
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Executive summary 
In recent decades, significant improvements in the health of the population of the WHO European 
Region have led to increases in life expectancy, which has reached over 76 years for both men and 
women. This is mainly a result of decreases in certain causes of death and advances in tackling the 
prevalence of risk factors and socioeconomic and living conditions. Nevertheless, these 
improvements and the conditions that foster them have not been shared equally within and between 
countries: substantial differences persist and in many instances are increasing. Health inequalities 
and their determinants occur – and in some cases are widening – in many parts of the Region. 
Avoidable inequalities that can be addressed by current knowledge are unfair, representing health 
inequities. 
As European populations are rapidly ageing, disease patterns are changing, creating different 
demands on the health and social sectors. Important demographic and epidemiological changes are 
occurring at different paces and varying intensity across the Region. Renewed efforts to implement 
cost-effective, evidence-based interventions and to orient policies to enhance health and well-being 
are provided under the framework of the Health 2020 strategy (1). This builds on and extends the 
focus of the European health report 2009 (2) on approaches to strengthen health systems’ functions 
based on cost-effective interventions and performance assessment. 
The goal of the European health policy, Health 2020, is “to improve the health and well-being of 
populations, reduce health inequities, and ensure sustainable people-centred health systems” (1). 
Through an intense process of consultation and the work of several expert groups, Health 2020 has 
arrived at six goals (overarching targets) for the European Region to achieve by 2020; for each area, 
indicators will be used to monitor progress. The use of targets builds on previous European efforts, 
such as those of Health for All and HEALTH21 (3,4). Valuable lessons have been learned from the 
nearly 30 years of experience in making health policy and setting targets. The process of setting 
targets and indicators is complex; this report clearly documents the procedures used to date in 
Health 2020 and outlines the next steps. 
A core aspect of Health 2020 is the measurement of population well-being, specifically in the 
context of health. The WHO definition of health as “a state of complete physical, mental and social 
well-being and not merely the absence of disease or infirmity” (5) recognizes the pivotal role of 
well-being, but WHO has neither measured nor reported on well-being. To incorporate well-being 
in Health 2020 and to quantify a European target and relevant indicators, it is essential to develop a 
common concept and approach to well-being that allow for valid measurement and yield 
information that is useful to policy-makers and for programme evaluation. 
 xi 
 
Researchers, organizations, governments and other entities take a wide range of approaches to 
describe in detail what areas or domains make up well-being in an intersectoral sense. WHO is 
working with its partners to address well-being in the context of health, and to connect this with the 
quantification of the burden of disease and assessment of health systems’ performance in the 
European Region. 
Further, this report acknowledges the challenges in measuring progress towards Health 2020, 
outlining with its partners an agenda to overcome them. Although health information is abundant in 
the European Region, data relevant to measuring progress are not readily available for all countries. 
The WHO Regional Office for Europe is supporting countries in enhancing their collection, 
collation, analysis and reporting of health information, and working with the European Commission 
and the Organisation for Economic Co-operation and Development (OECD) to establish a single 
integrated health information system for Europe, covering all 53 Member States. 
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1. Where we are: health status in Europe and the case for Health 2020 
People in Europe are living longer than ever before; we in the WHO European Region are also 
living healthier lives. Nevertheless, as this chapter outlines, the benefits gained in recent decades 
are not equally distributed across the Region, or reaped by all parts of Europe or all population 
groups. In some countries, health and life expectancy have declined, widening the health gap across 
the Region. This is intolerable in a region of immense wealth and public health traditions, and calls 
for an urgent implementation of the new European health policy, Health 2020 (1). 
The European Region is undergoing important demographic and epidemiological changes that are 
shaping its future needs for health promotion, disease prevention and care. Nevertheless, such 
transitions are occurring at varying speed and intensity for different countries and populations, 
creating new challenges and a mosaic of health situations that requires specific approaches. This 
evolving context highlights some of the major challenges for health in Europe, which the Health 
2020 policy addresses (1). The information provided in this chapter mostly reflects data reported by 
countries to the WHO Regional Office for Europe (Box 1). It identifies key areas on which the 
Health 2020 policy is based, highlights patterns that demand attention and provides a baseline for 
the monitoring of progress towards defined priorities and areas for policy action. 
Box 1. Approach to preparing graphs and interpreting data 
• Data presented in this report are mostly from the European Health for All database (6) as reported by 
countries or other international organizations to the WHO Regional Office for Europe. 
• Although the WHO European Region includes 53 countries, the number of countries with data for any 
given year may vary between indicators, owing to differences in the reporting or availability of data. 
• The average value for the European Region for any given indicator represents the population-weighted 
average of country data. Unlike previous reports, this edition of the European health report does not 
provide averages for different subregional groupings of countries. Developing a new, meaningful 
approach to present subregional data that accurately reflect the contemporary context and are useful 
for monitoring progress towards the Health 2020 policy is one of the measurement and analysis 
challenges noted in the last section of this report. 
• The shaded areas in the graphs show trends, usually between 1980 and 2010, and represent the minimum 
and maximum country values for a particular indicator for a specific year (see Fig. 1). This means that 
different countries may represent the minimum or maximum value in different years. Countries in the 
Region vary in size and, for those with smaller populations, a few cases may determine whether a 
country has the minimum or maximum value. 
• These points partly explain some of the extreme spikes observed in the shaded areas in different graphs. 
Nevertheless, these spikes may sometimes represent extreme situations: for example, increased 
mortality (or reduced life expectancy) following a significant natural disaster or man-made 
catastrophe. 
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Demographic trends 
Population growth and ageing 
The population of the 53 countries in the European Region reached nearly 900 million in 2010, an 
increase of 5% since 1990 (6). Projections from 2010 onwards suggest that the population will not 
change significantly in the Region as a whole in the coming decades but that it will actually 
decrease in some countries (7). Several factors contribute to this trend, including lower crude birth 
rates (Fig. 1) along with fertility rates lower than 1.75 children per woman and relatively stable or 
slowly increasing crude death rates and migration inflows. A decrease, or negative annual 
population increase, has already been documented in central and eastern European countries from 
the early 1990sto the early 2000s. 
Fig. 1. Crude birth rate in the European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
The population in the European Region is ageing rapidly. By 2010, an estimated 15% of the overall 
population was aged 65 years and over (Fig. 2). This represents an increase of nearly 30% since 
1980; this age group is the fastest growing segment of the population. Countries in the Region show 
important differences, however, in the proportion of people aged 65 years and over, ranging from 
more than 20% and increasing to 5% and potentially falling further. Nevertheless, this age group is 
projected to represent more than 25% of the total population of the European Region by 2050. 
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Fig. 2. Population aged 65 years and over in the European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
Overall, the ageing of the population is associated with the increased control of communicable 
diseases early in life, the delayed occurrence of chronic noncommunicable conditions and reduced 
premature mortality, reflecting improvements in living conditions and health services. Nevertheless, 
continuing to ensure and strengthen social inclusion, security and welfare – along with a range of 
health and social services in line with the needs of an ageing population, given this well-
documented phenomenon and its expected effects –should be a high priority, requiring adequate 
resources adapted to the context of each country (8). 
Population distribution 
Migration is an additional factor influencing the demographic transitions observed in Europe. The 
main contributing causes are natural and man-made disasters, as well as social, economic and 
political disruptions. Based on reported data, an estimated 73 million migrants live in the European 
Region, accounting for nearly 8% of the total population, with women representing 52% of all 
migrants. Overall, this population inflow reflects a 5 million increase to the Region’s population 
since 2005 and accounts for nearly 70% of the population growth between 2005 and 2010. 
Existing net migration estimates and projections to 2020 document and predict dramatic changes 
and differences across countries in the Region. With a baseline in 2000, Fig. 3 illustrates the 
projected net migration to 2020 across countries in the European Region. 
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Fig. 3. Projected net change in migration rates in countries in the European Region, 2000–2020 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: World Population Prospects 2008, United Nations Population Division (7). 
The long-term effects of migration on sustained population growth and structure remain uncertain. 
Some facts are well documented: migrants are usually younger, less affluent and more likely to 
become ill, and have less access to health services than the rest of the population. Taking this into 
account, government policies across different sectors will benefit from coordinated strategies that 
give special attention to the current and future needs of migrants. Across the European Region, 
sharing experiences and evidence gained through the implementation and evaluation of strategies in 
health systems and other social and economic systems should be further encouraged. 
The geographical distribution of the population in the Region provides additional insights relevant 
to health policy. Nearly 70% of the overall population lived in urban settings in 2010; this 
proportion is expected to exceed 80% by 2045 (9). The proportion of the population in urban areas 
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varies between countries, however, ranging from more than 85% in about 10 countries to less than 
50% in 8 countries. Urban and rural populations may differ in their exposure to a wide range of 
social determinants of health, including access to health and other services (see the section on social 
determinants and health inequalities below). Similarly, urban centres have diverse social and 
economic conditions, and countries have different policies addressing, for example, social inclusion 
or the processes that render some people more vulnerable to illness. 
Box 2. Key messages – demographic trends 
• While the population of Europe has grown to nearly 900 million inhabitants, decreasing fertility rates 
across the Region mean that this trend will soon plateau. 
• The population is ageing rapidly, with projections estimating that more than 25% of the total population of 
the European Region will be aged 65 and over by 2050. 
• Migration is influencing the demographic transitions observed in Europe. 
• The proportion of the population living in urban areas reached nearly 70% in 2010 and is expected to 
exceed 80% by 2045; as a consequence, people are exposed to different health risks and determinants. 
Epidemiological situation and trends 
In addition to these demographic changes, the population of the European Region is experiencing 
important epidemiological changes in mortality, reflecting changing patterns across age and sex 
groups, and in the causes of disease and disability. The following sections illustrate trends, offer a 
baseline for Health 2020 and provide information that points to focus areas for promoting health, 
preventing disease and strengthening health systems across the Region. 
Life expectancy 
Life expectancy at birth 
Although based on mortality rates, overall life expectancy is a widely used indicator of health. A 
major success for the European Region is that life expectancy at birth has increased by 5 years since 
1980, reaching 76 years in 2010. This translates to an average annual gain of 0.17 years for the 
period and, except for two dips around 1984 and 1993, a steady upward increase. 
Nevertheless, average life expectancy at birth differs across countries, ranging from 82.2 years to 
68.7 years, giving a gap of 13.5 years for 2010 (Fig. 4). Over time, three distinct periods can be 
noted in terms of inequalities. During the 1980s the highest and lowest levels were converging, 
showing inequalities across countries narrowing. Following the mid-1990s, inequalities slowly 
widened, coinciding with significant social, political and economic change in the eastern part of the 
Region. Since 2006, the upper and lower extremes have slowly begun to converge again. 
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Fig. 4. Life expectancy at birth in the European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
Life expectancy at birth across the European Region also differs between men and women, 
highlighting a fundamental and persistent inequality in the Region. In 2010, women’s life 
expectancy has reached an average of 80 years, while men are living an average of 72.5 years, 
giving a gap of 7.5years. Fig. 5 illustrates that, on average, men are lagging behind women in life 
expectancy by a generation, as in 2010 men had not yet reached the average level women enjoyed 
in 1980. There are also larger inequalities across countries for male life expectancy, in comparison 
to female life expectancy, particularly after 1993. 
Fig. 5. Male and female life expectancy at birth in the European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
Large inequalities in average life expectancy at birth are also documented across 46 countries 
reporting data in 2006–2010 (Fig. 6), with 26 countries above and 20 below the average for the 
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Region. Inequalities are especially prominent when life expectancy is analysed by sex (Fig. 7). On 
average, the gap between countries is wider for men (17 years) than women (12 years). 
With a few exceptions, inequalities in life expectancy between men and women tend to be widest in 
countries with lower overall life expectancy levels (for example, below 80 years for women). The 
smallest within-country differences by sex (4 years or less) are seen in Iceland, Israel, the 
Netherlands, Sweden and the United Kingdom, while male–female gaps of 10 years or more occur 
in Belarus, Estonia, Kazakhstan, Lithuania, Montenegro, the Russian Federation and Ukraine. This 
suggests that, as countries increase their overall life expectancy, they also become more equitable, 
as the disparities between males and females tend to narrow, potentially challenging the view that 
there is a static, biological explanation for females having higher life expectancy. Reducing 
inequalities in life expectancy between men and women requires action on the social determinants 
of health, including more balanced gender norms, roles and behaviour, which enable men and 
women equally to obtain the highest standard of health. 
Another dimension to compare across countries is the rate of improvement. Fig. 8 documents 
differences in improvement in life expectancy at birth between 1995 and 2009 in countries. 
Progress by country in terms of percentage gains during these 14 years varied from less than 1% to 
more than 10%. The rate of improvement was relatively faster in the eastern and central parts of the 
European Region than in other areas. Women in France, Italy and Spain gained over 3 years to 
reach a life expectancy at birth of nearly 85 years: the highest level in the European Region. On 
average, women in these countries also outlived their countrymen by 5–6 years. In the same period, 
some countries with lower life expectancy at birth – such as the Czech Republic, Estonia, Hungary, 
Ireland, Israel, Luxembourg, Poland, Romania, Turkey and the United Kingdom –gained more than 
5 years among either men or women. Men in some countries, however, mainly in the eastern part of 
Europe, lost or had only marginal gains (up to 1.4 years). Nevertheless, even though men have 
lower absolute levels of life expectancy at birth, they generally had larger proportional gains in 
1990–2010 than women. 
Life expectancy of older people 
More people in the European Region are living past the age of 65. Life expectancy at 65 is 
15.5 years on average (Fig. 9), with older women expected to outlive older men by nearly 4 years. 
As with life expectancy at birth, on average, men have not reached the life expectancy at 65 in 2010 
that women reached in 1980. Large inequalities between men and women also exist within different 
countries. 
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Fig. 6. Life expectancy at birth in countries in the European Region, last reported data, 2006–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
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Fig. 7. Male and female life expectancy at birth in countries in the European Region, last reported 
data, 2006–2010 
 
 
Source: European Health for All database (6). 
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Fig. 8. Gains in life expectancy at birth in the European Region, 1995–2009 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
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Fig. 9.Male and female life expectancy at age 65 in the European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
Life expectancy may be further broken down to account for the length of life lived in less than full 
health due to disability and disease at different ages; this is a useful tool for health policy-makers. 
Although women in the European Region live on average 7.5 years longer than men, the average 
difference by sex in healthy life-years is estimated to be only 5 years, indicating that women live a 
smaller proportion of their lives in good health than men (10). 
As a consequence of the ageing of a population, additional demands need to be met for necessary 
health care (particularly long-term care), which requires planning to ensure an adequately trained 
health workforce. At the same time, healthy older people are a repository of knowledge and a 
resource for their families and communities, and in the formal or informal workforce. Monitoring 
the health and well-being of populations at all ages, including those over 65, and throughout life is 
the subject of Chapter 3. 
A scenario threatening the European Region’s overall sustained gains in life expectancy may occur 
if economic or social crises are coupled with reductions in spending on health and other services 
and safety nets, increases in environmental disasters, increasing rates of harmful behaviour or new 
and re-emerging infectious diseases with high pathogenic and pandemic potential. To sustain the 
average gains in life expectancy, continuous efforts are required to decrease mortality, particularly 
from diseases of the circulatory system, respiratory and infectious diseases, and external causes of 
injury and poisoning. The following sections describe trends in mortality across the European 
Region. 
Box 3. Key messages – life expectancy 
• A major success for the European Region is that life expectancy at birth has increased by 5 years since 
1980, reaching 76 years in 2010. 
• Average life expectancy at birth differs across countries, ranging from 82.2 years to 68.7 years, giving a 
gap of 13.5 years for 2010. 
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• Inequalities in life expectancy between men and women tend to be widest in countries with lower overall 
life expectancy levels: for example, below 80 years for women. 
• In 2010, women reached an average life expectancy of 80 years while men lived an average of 72.5 years, 
giving a gap of 7.5 years. There are also larger inequalities across countries for male life expectancy in 
comparison to female life expectancy, particularly after 1993. 
• More people in the European Region are living past the age of 65. Life expectancy at 65 is 15.5 years on 
average. 
Mortality 
Mortality continues to be one of the most robust indicators for monitoring the situation and trends 
of disease impact in a population. With information on the magnitude, groups affected, and 
underlying causes and other contributing factors, more specific priorities and policies may be 
established to address the burden of disease and to identify cost-effective and equity-promoting 
strategies to decrease mortality and enhance well-being. 
Overall mortality 
Overall mortality from all causes of death continued to decline in the European Region, reaching an 
age-standardized rate of 813 deaths per 100 000 population in 2010 (Fig. 10). Nevertheless, 
variation in the Region has increased since 1993. Country-specific mortality rates range from a high 
of 1452 to a low of 497 per 100 000, giving a threefold inequality gap in the Region (Fig. 11). 
Fig. 10. All-cause mortality rate in the European Region, 1980–2010 
 
Source: European Health for All database (6). 
All-cause mortality shows a geographical gradient, with the highest rates in the eastern part of the 
Region and the lowest towards the western part of the Region (Fig. 12). 
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Fig. 11. All-cause mortality rates in countries in the European Region, last reported data, 2006–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
  
0
200
400
600
800
1000
1200
1400
1600
K
a
z
a
k
h
s
t
a
n
R
u
s
s
i
a
n
 
F
e
d
e
r
a
t
i
o
n
R
e
p
u
b
l
i
c
 
o
f
  …
U
k
r
a
i
n
e
K
y
r
g
y
z
s
t
a
n
B
e
l
a
r
u
s
L
a
t
v
i
a
L
i
t
h
u
a
n
i
a
A
r
m
e
n
i
a
B
u
l
g
a
r
i
a
R
o
m
a
n
i
a
S
e
r
b
i
a
E
s
t
o
n
i
a
H
u
n
g
a
r
y
M
o
n
t
e
n
e
g
r
o
A
z
e
r
b
a
i
j
a
n
S
l
o
v
a
k
i
a
G
e
o
r
g
i
a
C
r
o
a
t
i
a
P
o
l
a
n
d
C
z
e
c
h
 
R
e
p
u
b
l
i
c
D
e
n
m
a
r
k
S
l
o
v
e
n
i
a
P
o
r
t
u
g
a
l
M
a
l
t
a
G
r
e
e
c
e
L
u
x
e
m
b
o
u
r
g
I
r
e
l
a
n
d
U
n
i
t
e
d
 
K
i
n
g
d
o
m
F
i
n
l
a
n
d
B
e
l
g
i
u
m
G
e
r
m
a
n
y
N
e
t
h
e
r
l
a
n
d
s
A
u
s
t
r
i
a
C
y
p
r
u
s
I
s
r
a
e
l
N
o
r
w
a
y
S
w
e
d
e
n
S
p
a
i
n
F
r
a
n
c
e
I
c
e
l
a
n
d
I
t
a
l
y
S
w
i
t
z
e
r
l
a
n
d
A
g
e
‐
s
t
a
n
d
a
r
d
i
z
e
d
 
m
o
r
t
a
l
i
t
y
 
r
a
t
e
 
p
e
r
 
1
0
0
?
0
0
0
 
p
o
p
u
l
a
t
i
o
n
,
a
l
l
 
a
g
e
s
European Region 
 14 
 
Fig. 12. All-cause mortality in countries in the European Region, last reported data, 2006–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
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Effects by age 
Mortality patterns by age in the European Region follow a J shape characteristically found in 
populations with more advanced demographic transitions, who benefit from higher socioeconomic 
development. Average all-cause mortality rates tend to be low or very low during early years of life 
up to young adulthood, and then rapidly increase two- to threefold across the Region, continuing to 
do so into older ages (Fig. 13). 
Fig. 13. All-cause mortality rate by age group in the European Region, 2009 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European mortality database (11). 
A more detailed look at all-cause mortality by broad age groups between 1980 and 2010 shows that 
mortality rates decreased steadily, except for the well-documented increase in 1993–1995, most 
particularly for the group aged 30–59 years (Fig. 14). Variation in mortality rates increases for each 
broad age group. Country-specific differences range from less than 50% below to more than 70% 
above the regional average. 
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Fig. 14. All-cause mortality rates by broad age group in the European Region, 1980–2010 
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Source: European mortality 
database (11). 
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Child and maternal mortality 
Indicators of child health, such as infant and child mortality, are often used to monitor health in a 
population. This is because of the special vulnerability of members of this age group: their 
sensitivity to overall living conditions and other social determinants of health, including access to 
health services. Infant and child mortality continues to influence life expectancy in several countries 
in the European Region. Child health indicators are frequently used to identify targets – such as 
Millennium Development Goal (MDG) 4 on reducing the mortality rate for children under 5 years 
by two thirds by 2015 (12) – and to measure countries’ progress. 
Infant mortality rates in the European Region have continued to decline since 1990 and are the 
lowest in the world (Fig. 15). The average reported infant mortality rate in 2010 (deaths before 1 
year of age relative to live births) was 7.3 per 1000: a 53% reduction over three decades. Moreover, 
variations across countries have declined, particularly since 1997.Yet countries report strikingly 
different rates, ranging from more than 50% below to more than 60% above the regional average. 
Data on the probability of a child’s dying before the age of 5 years (not shown) reveal a very similar 
pattern, with countries across the European Region reporting reductions. Most countries in the 
Region have made important progress towards MDG 4; only a few still have high child mortality 
levels. The target set seems to be within reach in most European countries. 
Fig. 15. Infant mortality rate in the European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
Maternal mortality is another important indicator of population health, as well as gender equality. 
The maternal mortality ratio provides information on access to and the quality of health care, as it 
spans antenatal, delivery and post-natal care. It is also the core outcome indicator for MDG 5 (13), 
which aims for a three-quarters reduction in maternal mortality by 2015. The European Region’s 
mortality ratio for 2010 was 13.3 maternal deaths per 100 000 live births. Variation is high, ranging 
from more than 75% above to more than 60% below the regional average (Fig. 16). Since 1990 the 
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average maternal mortality ratio has fallen by 50%, and inequalities have narrowed. A small 
increase in the eastern part of the Region in 2009could be attributed to increased vulnerability 
linked to pandemic influenza, which increased hospitalizations and severe respiratory diseases 
worldwide. 
The main causes of maternal death are obstetric haemorrhage, hypertension and infection, much of 
which can be prevented by basic, evidence-based and cost-effective interventions (14). In addition, 
the socioeconomic status of women – including their level of education – clearly contributes 
directly to maternal mortality. This highlights the importance of addressing gender norms and other 
social determinants of health in policies and interventions, and of taking a human rights-based 
approach to providing the services needed, including emergency obstetric services without financial 
burden on households. 
Fig. 16. Maternal mortality ratio in the European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
Older populations 
As the European population ages, mortality trends help to anticipate some of the challenges that 
health and other social systems will face in the future. Trends by broad age groups, such as those 
aged over 65, provide greater insight into the approach that health systems will need to adjust and 
respond appropriately to the evolving needs. Moreover, consideration has to be given to the facts 
that women live longer than men yet also live a greater share of their lives in poorer health, with 
issues including a higher frequency of multiple diseases occurring simultaneously and higher 
disability rates (15). 
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The all-cause mortality rate among people aged 65 years and over is decreasing in the European 
Region as a whole, reaching its lowest rate, 4549 per 100 000, in 2010: a 25% decrease since 1980 
(Fig. 17). The minimum and maximum points indicate significant differences across countries, 
whose rates ranged from more than 20% below to more than 40% above the regional average. Close 
monitoring of these trends at the regional and country levels is warranted. 
Fig. 17. All-cause mortality rate for people aged 65 years and over in the European Region, 1980–
2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source European Health for All database (6). 
Box 4. Key messages – mortality 
• While overall mortality from all causes of death in the European Region continues to decline, mortality 
trends show large gaps between country groups. 
• Mortality by age in the Region follows a pattern in which rates tend to be low or very low during early 
years of life and young adulthood, after which they increase rapidly. 
• Child mortality indicators in the European Region are the lowest in the world, with a rate of 7.9 per 1000 
live births. Nevertheless, country rates show striking differences, ranging from 50% below to 60% 
above the regional average. 
• The maternal mortality ratio for the Region was 13.3 deaths per 100 000 live births in 2010, a 50% 
reduction since 1990. Again, there is much variation across countries. 
• All-cause mortality among people aged over 65 has decreased in the European Region, but countries show 
important differences in levels and patterns. These trends will help to anticipate some of the challenges 
facing health systems today and in the future. 
Causes of death 
Using causes of death to disaggregate all-cause mortality data allows their distribution and 
magnitude in a population to be identified, providing information used for policy and programme 
formulation. In the European Region, disease patterns are changing and health problems emerging 
that are associated with its level of demographic and epidemiological change and social and 
economic circumstances. 
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Major causes 
The mortality rate associated with all individual major causes – for both males and females, 
combining all age groups – decreased in the Region between 1990 and 2009 (Fig. 18). 
Noncommunicable diseases (NCDs) account for the largest share of mortality: about 80% of deaths 
in 2009. Among broad groups of causes, diseases of the circulatory system account for nearly 50% 
of all of deaths, with higher rates among men than women. Proportions in countries ranges from 
less than 30% to more than 65% of all deaths. Cancer (neoplasm) mortality follows in frequency, 
accounting for 20% of deaths in the Region, ranging from around 5% to more than 30% in some 
countries. The third major cause of mortality is external causes of injury and poisoning, 
representing 8% of all deaths, again with variation across countries. 
Age and sex profiles of causes 
Mortality profiles by age and sex groups allow the relative importance of causes of death occurring 
at different stages across the life course to be visualized, and provide input in developing targeted 
strategies and interventions (Fig. 19). For example, respiratory diseases and external causes account 
for nearly 60% of all deaths among infants. These diseases subsequently predominate, along with 
neoplasms, up to just before the age of 15 years, accounting for nearly 75% of all deaths. For people 
aged 15–39 years, external causes are the main causes of death, particularly among men. Women in 
this same age group are more likely than men to die from neoplasms. Diseases of the circulatory 
system and neoplasms play an increasing role during adulthood until older ages, accounting for 
nearly 80% of deaths. 
Fig. 20 illustrates the variation and pattern of mortality by the six broad causes of death for each 
country in the European Region reporting recent data. The next section examines a range of specific 
causes of mortality across the Region in greater detail. 
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Fig. 18. Causes of death by main broad group among males and females in the European Region, 1990 and 2009 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
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Fig. 19. Mortality profiles by cause of death, age and sex in the European Region, last reported data, 2006–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European detailed mortality database (16). 
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Fig. 20. Mortality rates by main broad group of causes of death in countries in the European Region, last reported data, 2006–2010 
 
 
Source: European Health for All database (6). 
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Specific causes 
More than 70% of mortality occurs at ages over 65 years, when people have been ill for several 
years. Assessment of premature mortality (deaths occurring before the age of 65 years) is 
informative for developing public health priorities, policies and programmes aiming to delay 
disease and the onset of disability. 
The trends show that diseases of the circulatory system have remained the most important cause of 
premature death in the European Region, with a rate approaching 100 per 100 000 population in 
2010. The highest level in the past 20 years was recorded in 1995, after which there was a 30% 
decrease (Fig. 21). The cancer rate also decreased by 20% in this period. The largest health gains 
have been observed in external causes, the rate of which declined by 50%. In contrast, rates of 
diseases of the digestive system and infectious and parasitic diseases increased by nearly 30%, 
although these diseases occur less frequently than the others. The variations over time in both 
diseases of the circulatory system and external causes could well be related to increased stress and 
economic difficulties experienced in some countries in the Region (Fig. 22). 
Fig. 21. Trends in premature mortality by main broad group of causes of death in the European 
Region, 1990–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
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Fig. 22. Premature mortality rates by main broad group of causes of death in the European 
Region, 1980–2010 
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Source: European Health for All database (6). 
Premature mortality for the main causes of death has shown decreasing trends over the past 30 
years, with the exception of diseases of the digestive system and infectious and parasitic diseases. 
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Premature mortality from cardiovascular disease varies widely across the Region; that from cancer 
varies less, and the following sections further discuss these trends. 
Diseases of the circulatory system 
The main diseases of the circulatory system are ischaemic heart and cerebrovascular diseases, 
which together account for 35% of all deaths in Europe. The most recent data indicate that the 
mortality rate for diseases of the circulatory system varies widely between countries in the Region 
(Fig. 23), and by age, sex and the distribution of important determinants. For example, the European 
regional average rate of premature mortality from ischaemic heart disease is 47.5 per 100 000, but 
within individual countries the rate can be about five times higher for men than women (Fig. 24). 
For men, the maximum rates are nearly 13 times the minimum country values.  
Although premature mortality from ischaemic heart disease is generally decreasing, in some eastern 
countries in the Region the rate is decreasing more slowly, stagnating or – worryingly – slightly 
increasing. Premature mortality from cerebrovascular diseases shows similar patterns and trends in 
the Region. Evidence indicates that this challenge can be improved by countries’ addressing a 
combination of preventable factors, including high alcohol intake and binge drinking, increasing 
stress levels and reduced social support.  
Moreover, a global assessment has documented that almost 50% of the burden of these diseases 
may be attributed to high blood pressure ( 115 mm Hg systolic) (17). Broad social and economic 
determinants of health, such as economic downturns, exacerbate these risk factors. Coordinated 
policies and interventions need to consider these factors and address a combination of determinants 
(such as obesity, high salt intake and physical inactivity) as priorities for improving overall health 
and well-being and reducing premature mortality from diseases of the circulatory system. 
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Fig. 23. Premature mortality from ischaemic heart disease in the European Region, last reported data, 2006–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
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Fig. 24. Premature mortality from ischaemic heart disease among males and females in the 
European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
Cancer 
General situation 
Cancer is the second leading cause of mortality in countries in the European Region. According to 
the latest available data, neoplasms account for nearly 20% of all deaths in the Region. The 
mortality and incidence patterns vary according to the type of cancer, with lung and colon 
neoplasms having the highest overall mortality (Fig. 25). 
Specifically, lung, colon, stomach and prostate neoplasms account for nearly 50% of cancer deaths 
among men, while breast, lung, stomach, colon, cervical and ovarian neoplasms account for 60% of 
deaths among women. Reported cancer incidence data are sparser than mortality data, but are 
needed to calculate case fatality (see below). In 2008, GLOBOCAN (18) indicated that around 
2.5 million new cancer cases occur every year in Member States of the European Union (EU) – 
countries representing about 55% of the European Region’s total population. 
Across the Region, neoplasms with the highest incidence include those of the lung, female breast, 
colon and prostate, and these rates are expected to increase further by 2020. According to the Health 
for All database (6), overall cancer incidence in the European Region is 379 cases per 100 000, 
translating into a 32% increase since the mid-1980s. Incidence has almost doubled in some parts of 
the Region. 
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Fig. 25. Mortality from and incidence of cancer by main types in the European Region, 2010 and projected for 2020 
  
 
Source: European Health for All database and GLOBOCAN (6,18). 
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The overall increase in cancer incidence reflects the changing profile of causes of death resulting 
from the sustained reduction in mortality from diseases of the circulatory system, as well as the gain 
in life expectancy (see above). People are living longer, and most neoplasms develop over an 
extended time with a long latency period; this context has contributed to the increasing incidence. 
Moreover, neoplasms have replaced diseases of the circulatory system as the leading cause of 
premature death in 28 European countries, primarily in the western part of the Region. 
In general, overall cancer mortality in the Region has shown a decreasing trend since the mid-
1990s, with a 15% reduction to 2009 (Fig. 26). The regional average is 168 per 100 000, with an 
encouraging narrowing of inequalities since 2005. In terms of age and sex patterns, cancer mortality 
rates increase almost exponentially from 30 years of age onwards, and men experience higher rates 
than women at all ages. The risk for men is 50% greater by the age of 60 years and 100% greater 
(twice as high) by 65. 
Case fatality 
Combining mortality and incidence rates provides a crude estimate of case fatality, which is an 
indicator of survival from cancer after being diagnosed and provides insights into the effectiveness 
of disease screening, diagnosis and care. For lung cancer, the case fatality rate (mortality rates over 
incidence) for selected European countries was collectively 86% in 2008. Countries provided fairly 
consistent high case fatality rates, suggesting that there is no effective treatment or means to delay 
death after diagnosis with lung cancer. Five-year survival estimates from a recent EUROCARE-4 
report (19) showed no major changes in low survival rates (below 10%) over a ten-year period, 
supporting this hypothesis.  
Fig. 26. Mortality from cancer in the European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
There is a contrasting picture for female breast cancer, which shows an average case fatality rate of 
30%. The EUROCARE-4 study (19) indicates that five-year survival is relatively high and 
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increased from 74% to 83% over a ten-year period. In spite of different incidence levels in 
countries, mortality tends to be similarly low, suggesting the effectiveness of schemes for early 
diagnosis and treatment of breast cancer. 
Main types of cancer 
Mortality rates by main types of cancer among women and men indicate that lung cancer (which is 
highly preventable, as the main cause is tobacco smoking) is responsible for the greatest number of 
deaths in the European Region, followed by colon and stomach cancers (Fig. 27). The overall 
mortality rate for lung cancer was 17 per 100 000 in 2009, with variation across the Region. 
Proportionally, lung cancer is 2–3 times more frequent than colon cancer. Among females, breast 
cancer is responsible for the greatest number of deaths, with average mortality rates of 14 per 
100 000, followed by cervical and ovarian cancers. Breast cancer rates appear relatively uniform 
across the Region. 
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Fig. 27. Mortality from main types of cancer in the European Region, 1981 and 2009 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European mortality database (11). 
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Types of cancer affecting men and women 
The trend for average premature mortality (deaths occurring before the age of 65 years) from lung 
cancer in the Region has two distinct periods: an increase in 1980–1990 and subsequently a gradual 
decrease. Nevertheless, variation is substantial, as some countries experienced rates twice the 
regional average until recently (Fig. 28).  
Fig. 28. Premature mortality from lung cancer in the European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
Moreover, countries reported substantial decreases between 1995 and 2009, particularly in the 
eastern part of the Region (Fig. 29), although rates continue to increase in some. On average, rates 
are decreasing for men but stagnating or increasing for women. Nevertheless, overall premature 
deaths from lung cancer remain more than twice as high for men in the Region (Fig. 30). 
At the country level, mapping premature mortality from lung cancer across the Region shows that 
the highest rates are found in central Europe (Fig. 31), where rates are over 25 per 100 000. Higher 
rates are also associated with higher prevalence of tobacco smoking, which in turn is determined 
and shaped by the affordability of tobacco products, limited restrictions on advertising (among other 
marketing strategies) and other national policies that do not consider public health priorities. 
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Fig. 29. Changes in premature mortality from lung cancer in the European Region, 1995–2009 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
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Fig. 30. Premature mortality from lung cancer among males and females in the 
European Region, 1980–2010 
 
Source: European Health for All database (6). 
Other, less prevalent but important forms of cancer include those of the stomach, 
colon and liver. In comparison to lung cancer levels and trends, these types of cancer 
present more diverse patterns and greater inequality across the Region (Fig. 32). 
Second to lung cancer, premature mortality from colon cancer declined marginally 
from its highest levels in the early 1990s to 7 per 100 000 in 2010; the decrease is an 
example of the reversal of an increasing trend during the 1980s with measurable 
improvements. The contributory factors include the effects of screening, earlier 
diagnosis and more effective treatment schemes. Ensuring that the benefits of these 
practices are available across the European Region is one priority in the fight against 
premature mortality. 
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Fig. 31. Premature mortality from lung cancer in the European Region, last reported data, 2006–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
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Fig. 32. Premature mortality from lung, stomach, colon and liver cancer in the European Region, 
1980–2010 
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Source: European mortality database (11). 
Turning to the overall pattern of stomach cancer, since 1980 the Region has had steady and 
sustained reductions of nearly 60%, resulting in a premature mortality rate of 5 per 100 000 in 2009. 
Progress may be attributed to the reduced consumption of some carcinogenic products (such as 
nitrates) and the discovery and treatment of Helicobacter pylori, a pathogen that facilitates 
carcinogenesis. Despite variation, countries in the eastern part of the Region have made significant 
progress and are converging towards rates found in the central and western parts. 
Liver cancer, however, shows a different pattern. Although the absolute level is lower, premature 
mortality is increasing – particularly since 1995 – reaching an overall rate of 3 per 100 000 for the 
European Region, with country-level trends beginning to move towards convergence. Verifying 
whether this is an effect change due to diagnosis or classification codes will require additional 
assessments of associated conditions and risk factors, such as the patterns of chronic liver disease 
and alcohol consumption. 
Types of cancer affecting women 
Breast cancer is responsible for the highest cancer mortality rate among women, with relatively 
uniform rates across the Region. This remains the case, although overall premature mortality rates 
in the Region have decreased to a level of 14 per 100 000, an important reduction of 21% since the 
peak in around 1995 (Fig. 33). 
According to the latest reported data, mortality trends are converging, though some additional effort 
must be made in the eastern part of the Region to align with the others. Innovations in medical 
technology (including diagnosis, treatment and surgical procedures), combined with greater access 
to these innovations, have led to reduced mortality in spite of high incidence: that is, lower case 
fatality rates. As with colon and stomach cancers, this represents an important success for the health 
sector and for wider public health actions, including those of many nongovernmental organizations. 
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Fig. 33. Premature mortality from breast cancer among females in the European Region, 1980–
2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
The distribution of premature breast cancer mortality rates at the country level shows a different 
pattern from other diseases (Fig. 34), with lower rates in the southern and northern parts of Europe, 
possibly associated with some cultural and genetic factors. The gap between the highest (20 per 
100 000) and lowest (6 per 100 000) country mortality rates represents a threefold difference in the 
risk of women dying from breast cancer. 
Tackling cervical cancer – an important component of women’s health programmes in the Region – 
is an unfinished item on the health agenda. Knowledge and health technology to screen for, 
diagnose and treat this form of cancer are affordable and potentially available today, yet cervical 
cancer continues to occur and kill. This context is associated with a range of social determinants of 
health, including inequalities in access to health services, that lead to inequities in health outcomes. 
Nevertheless, universal policies addressing cervical cancer have shown an impact in countries: 
premature mortality trends at the regional level indicate that some level of control has been 
achieved. The most recent data show an average age-standardized mortality rate of 4 per 100 000 
(Fig. 35). Nevertheless, wide variation exists, indicating that continual sharing of best practices 
across the Region, as well as adaptation for implementation to different contexts, is warranted. 
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Fig. 34. Premature mortality from breast cancer among females in the European Region, last reported data, 2006–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
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Fig. 35. Premature mortality from cervical cancer among females in the European Region,  
1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
External causes of injury and poisoning 
Overall situation 
External causes of injury and poisoning are also important causes of mortality in the European 
Region, responsible for 9% of all deaths. They comprise a constellation of causes, including 
transport and motor vehicle accidents, falls, suicides and homicides. By definition, deaths from 
these causes are all premature and avoidable. Some argue against the use of the word “accidents”; 
for example, most transport crashes reflect a lack of policies or their implementation. In contrast to 
other causes of premature mortality previously described, examining the specific causes by all ages 
(across the life course) is vital. Moreover, mortality-related indicators are useful in providing 
information on environmental safety and security conditions, as well as the levels and trends of 
some harmful behaviour in the population. As indicated above (see Fig. 19), mortality rates for 
external causes are higher among men than women, and disproportionately concentrated during the 
most economically productive stage of life. 
Mortality from all external causes in the European Region reached 63 per 100 000 in 2010, having 
decreased by 20% since 1990 (Fig. 36). As noted in Box 1, spikes reflect natural disasters or man-
made catastrophes. Nevertheless, the most recent data show that significant variation remains at the 
country level, from less than 25 per 100 000 to more than 180 per 100 000, a sevenfold disparity 
(Fig. 37). Socioeconomic downturns are important social determinants of the mortality from 
external causes. 
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Fig. 36. Mortality from all external causes of death in the European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6).  
Main types 
In order of frequency, accidents (transport and motor vehicle, poisoning, falls, drowning, and 
exposure to smoke and fires), suicide and self-harm, and homicide and assault dominate mortality 
from external causes in the European Region. Reductions were documented between 1980 and 2009 
(Fig. 38), but there are significant differences across countries. For example, mortality rates from 
suicide, drowning, transport accidents and homicide are significantly higher (up to 1.5 times 
greater) in the eastern part of the Region, whereas falls are on the rise in the western part. 
Monitoring mortality trends for the main external causes provides additional useful information on 
the impact of social determinants of health. For example, suicide rates – one of the only indicators 
of mental health in the Health for All database – have decreased by 25–40% across Europe. 
Nevertheless, the rate of reduction has slowed since 2008, with some countries experiencing a 
reversal. Increasing suicide rates are often the tip of the iceberg, and do not necessarily represent a 
much broader range of psychological and neuropsychiatric conditions and their overall burden of 
disease. Moreover, other severe consequences for health are usually associated with economic 
downturns. This situation merits close monitoring and timely interventions to mitigate the potential 
psychosocial effects of lower income and unemployment, and processes that exclude different 
groups or individuals. Chapter 3 discusses approaches to monitoring broader components of health 
and well-being more fully. 
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Fig. 37. Mortality from external causes in the European Region, last reported data, 2006–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
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Fig. 38. Mortality from main external causes of death in the European Region, 1981 and 2009 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European mortality database (11). 
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Another important contributor to deaths from external causes is mortality from transport and motor 
vehicle accidents. Rates from these causes provide information on road safety (including 
infrastructure conditions), the effectiveness of protective measures and the enforcement of 
regulations in each country. At the European level, the rates of road traffic accidents with injuries 
have marginally decreased over the past three decades, and the rates of accidents involving alcohol 
are decreasing across the entire Region (Fig. 39), despite fluctuations at the country level. 
Fig. 39. Rates of road traffic accidents with injuries and involving alcohol in the European Region 
 
 
 
Source: European Health for All database, (6). 
Overall, the trends in external causes of death call out for specific strategies and more targeted 
health interventions, including intersectoral or joined-up policies and implementation strategies (for 
example, from the transport, justice, labour and financial sectors). Best practices can be scaled up 
within countries and shared between them to tackle deaths from external causes from a European 
perspective. 
0
10
20
30
40
50
60
70
80
90
100
1989 1994 1999 2004
Ro
ad
 tra
ff
ic
 ac
ci
de
nt
 ra
te
 pe
r 1
00
?00
0 
po
pu
la
ti
on
Year
Involving alcohol
0
100
200
300
400
500
600
700
800
900
1980 1985 1990 1995 2000 2005Ro
ad
 tra
ff
ic
 ac
ci
de
nt
 ra
te
 pe
r 1
00
?00
0 
po
pu
la
ti
on
Year
With injuries
 48 
 
Communicable diseases 
Major aspects 
Communicable diseases occur less frequently in the European Region than in other parts of the 
world. Nevertheless, their unexpected emergence or re-emergence –combined with the fast 
propagation and epidemic potential of some – contributes to avoidable illness, premature mortality 
and their potential threat to health. Preparedness for communicable diseases therefore remains high 
on the health agenda. Additional factors, such as increased population mobility and trade, 
concomitant infections and increased antimicrobial resistance, further compound their occurrence, 
spread and threat. 
In the European Region, concern currently focuses on tuberculosis, HIV/AIDS, other sexually 
transmitted diseases and viral hepatitis. Recent outbreaks of poliomyelitis, rubella and measles in 
different parts of Europe, however, have also re-emphasized the need to sustain or improve public 
health activities, such as surveillance and prevention of communicable diseases, involving health 
promotion and immunization. 
According to reported data from across the European Region, mortality from all infectious and 
parasitic diseases slowly increased in the last decade, from 10 per 100 000 in 1990 to 14 per 
100 000 in 2010 (Fig. 40), with significant variation: from less than 50% below to more than 50% 
above the regional average. Further assessment, using information from the European detailed 
mortality database (16), suggests that in some countries this may be attributed to increased mortality 
from septicaemia, particularly among older people. In addition, methicillin-resistant Staphylococcus 
aureus may play a role in this situation, although confirmatory studies are needed. Nevertheless, 
this highlights the increasing importance of antimicrobial resistance as very relevant to the 
European Region. 
Fig. 40. Mortality rate for all infectious and parasitic diseases in the European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
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Tuberculosis 
Tuberculosis (TB) is among the most significant infectious and parasitic diseases, representing over 
40% of mortality within this group of causes in the European Region. Following increases in the 
1990s, mortality rates for TB decreased by 30%, reaching a rate of 6 per 100 000 in 2010. 
Nevertheless, there is significant variation across the Region (Fig. 41). In the eastern part of the 
Region, after 10 years without change, an encouraging decreasing trend has recently been 
documented. TB incidence rates indicate that the risk of transmission has also decreased since 2000, 
to 35 new cases per 100 000 (Fig. 42). 
Although treatment success rates are not entirely satisfactory (only around 70%), earlier and 
accessible diagnosis, along with availability and adherence to short-course treatment, explains 
decreasing TB mortality and incidence trends. Nevertheless, some countries still face challenging 
situations and have pockets of populations at higher risk. For example, the WHO Regional Office 
for Europe’s interactive atlases (20) show that TB is highly concentrated in a few small deprived 
areas with a risk of mortality 14 times that in more affluent areas, suggesting the importance of 
social determinants of health for this cause of death. In parallel, co-infection with HIV offers a 
further challenge to reducing mortality from TB, particularly in areas where both infections coexist 
and where multidrug resistance is present. 
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Fig. 41. Mortality from TB in the European Region, last reported data, 2006–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
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Fig. 42.Incidence of TB in the European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
HIV/AIDS 
HIV incidence, rather than mortality, is the preferred measurement of the frequency and impact of 
HIV/AIDS. Annual HIV incidence has marginally increased and is potentially reaching a plateau at 
the regional level, according to the most recent data (Fig. 43). Yet HIV incidence varies widely 
across countries, as mapped by the latest reported data between 2006 and 2010 (Fig. 44).  
Fig. 43.Incidence rate for HIV in the European Region, 1985–2009 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
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Fig. 44. Incidence of HIV in the European Region, last reported data, 2006–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
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Importantly, with the wide availability of antiretroviral therapy in the European Region, progression 
from seroconversion to clinical disease is decreasing in most countries (data not shown). Lower 
reported rates can indicate that effective treatment of HIV-positive people plays an important role in 
reducing overt disease risk. Appropriate delivery mechanisms need to be in place in the diverse 
health systems across the Region, however, to reach all people without discrimination, and to 
provide the conditions to make this effort sustainable. 
Diseases of the respiratory system 
Mortality from respiratory diseases takes its toll on two distinct populations: children and older 
people. The main specific causes of death are chronic obstructive pulmonary disease (COPD), 
pneumonia, influenza and asthma; each is closely associated with outdoor and indoor environmental 
conditions and exposures. The interventions to prevent respiratory diseases often reflect wider 
social determinants of health that require some intersectoral action to ensure an impact that lowers 
disease incidence and severity. 
Rates of premature mortality from respiratory diseases have steadily decreased in the European 
Region, falling by 40% since the mid-1990s to a rate of 16 per 100 000 in 2010 (Fig. 45). 
Fig. 45.Premature mortality rate for respiratory diseases in the European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
COPD and pneumonia account for the greatest number of premature deaths from respiratory 
diseases and their mortality trend patterns offer two distinct scenarios: one with decreasing rates and 
another with relatively stable ones (Fig. 46). Mortality rates from COPD (with men more affected 
than women) have decreased across the Region, while pneumonia rates remained mostly unchanged 
for the past decade. 
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Fig. 46.Premature mortality rates for COPD and pneumonia in the European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European mortality database (11). 
This context suggests that some exposures have increased in parts of the Region, perhaps as result 
of pollution and poorer air quality from industrialization and increased transportation, damp 
housing and poor indoor air quality. At the same time, increased access to treatment and 
vaccination, improved housing conditions and enhanced environmental protection and regulations 
may have a positive impact across the entire Region. 
Diseases of the digestive system 
Another important group of causes of death in the European Region, diseases of the digestive 
system include chronic liver disease and cirrhosis, as well as ulcers of the stomach and duodenum. 
At the regional level, premature mortality from all digestive-system diseases showed an increasing 
trend from the late 1990s to 2005, with a subsequent slight reduction. The overall rate reached 25 
per 100 000 in 2010: a 30% net increase in the last two decades (Fig. 47). The harmful intake of 
some products, such as alcohol and some processed foods, contributes to these diseases.  
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Fig. 47.Premature mortality from all diseases of the digestive system, and chronic liver disease and 
cirrhosis, in the European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
Over the past decade, mortality from chronic liver disease and cirrhosis has stagnated (Fig. 47). 
Chronic liver disease has been associated with a range of viral causes (such as hepatitis B and C 
infections), toxins and drug misuse. Nevertheless, alcohol abuse, particularly at a heavy and 
sustained level, probably makes the largest contribution. Mortality from chronic liver disease and 
cirrhosis is therefore often used as a proxy measure of a wide range of health problems related to 
excessive alcohol consumption. According to recently reported data (2006–2010), premature 
mortality from chronic liver disease and cirrhosis across the Region ranges from less than 1 to more 
than 70 per 100 000 population (Fig. 48). Underreporting of this disease sometimes occurs, 
however, because of stigmatization. 
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It is well documented that people across Europe are increasingly drinking alcohol earlier in life, 
consuming large amounts and engage in binge drinking: all these behaviours increase the incidence 
of disease and the risk of death. These trends justify the scaling up of effective interventions across 
the Region to reduce consumption (21). 
Diabetes 
Diabetes is a major public health problem in Europe because of its direct and indirect effects on 
those with the disease. These range from renal, neurological and ophthalmological microvascular 
damage to vascular damage of the limbs, brain and heart, with various severe consequences. 
Diabetes is also an important and frequent risk factor for diseases of the circulatory system, with 
which it shares some risk factors, such as poor diet, lack of physical exercise and obesity (see the 
section on risk factors below). Although relatively easy to diagnose, diabetes remains largely 
undetected in many settings; thus, measures of hospitalization and premature mortality from 
diabetes are suggested as potential tracer indicators of the performance of health systems (22). 
In the European Region, premature mortality from diabetes decreased by 25% from 1995 to 2010, 
to 4 per 100 000. Countries vary, however, according to the most recent data reported (Fig. 49). 
Box 5. Key messages – causes of death 
• NCDs account for the largest proportion of mortality in the European Region: 80% of deaths in 2009. 
• Diseases of the circulatory system are the most important cause of premature mortality in the Region, 
accounting for nearly 50% of all deaths. Neoplasms are the second leading cause, accounting for 
nearly 20%, while external causes of injury and poisoning are responsible for 9%. 
• Disease mortality shows changing patterns in various parts of the European Region; it also varies greatly 
both between countries and by age and sex. 
• Since there has been a sustained decrease of mortality from diseases of the circulatory system and an 
associated increase in life expectancy, the risk of developing cancer – linked to long latency periods – 
is increasing. Neoplasms have replaced diseases of the circulatory system as the foremost cause of 
premature death in 28 countries in the Region. 
• Primary and secondary prevention, rather than treatment only, are effective measures to reduce premature 
mortality from diseases of the circulatory system and neoplasms. For those with no effective 
treatment, prevention is the only way to reduce impact until innovations in medical technology 
become available. 
• Communicable diseases, although occurring less frequently in Europe than the rest of the world, remain 
high on the health agenda. The main concerns are TB, HIV/AIDS and other sexually transmitted 
diseases, and viral hepatitis. 
• Mortality from infectious and parasitic diseases in the Region has slowly increased since 1990. 
• Trend patterns for HIV incidence differ across the Region, with higher rates in some central and eastern 
countries in the Region. AIDS incidence is decreasing, indicating the importance of effective treatment 
of people living with HIV. 
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Fig. 48. Premature mortality from chronic liver disease and cirrhosis in the European Region, last reported data, 2006–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European mortality database (11). 
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Fig. 49.Premature mortality from diabetes in the European Region, last reported data, 2006–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European mortality database (11). 
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Burden of disease – mortality, morbidity and disability 
The principle guiding the burden-of-disease approach is that the best estimates of incidence, 
prevalence and mortality can be generated by carefully analysing all available sources of 
information in a country or region and correcting for bias. The disability-adjusted life-year (DALY) 
– a time-based measure that combines years of life lost due to premature mortality and years of life 
lost due to time lived in states of less-than-ideal health – was developed to assess the burden of 
disease. As a metric of population health and an input to health policies, the DALY makes clear in 
the way it is calculated that mortality does not comprise the entire burden of disease, and that 
morbidity and disability have a significant share (23). Moreover, it is a gap measure, meaning that 
DALYs are lost from what would be potentially ideal or perfect health, if people did not experience 
any disease or disability and if death occurred at the highest life-expectancy rates observed in the 
world.  
Two additional considerations make the DALY attractive: as a metric it facilitates cross-country 
comparisons, and it can be broken down and linked to underlying determinants, risk factors and 
interventions to assess risk, effectiveness and cost–effectiveness (efficiency). The distribution of 
DALYs lost or saved can also guide analysis from an equity perspective. Together, this information 
can contribute to priority setting and increase national or regional evidence on what interventions 
can avoid the greatest loss of DALYs. 
The distribution of the European Region’s total burden of disease for 2004 shows a range of10–28 
estimated DALYs lost per 100 population, depending on the country: this represents an almost 
threefold gap between the best country situation and the least favourable one (Fig. 50). Men lost 
about 20% more DALYs than women. 
Projections of DALYs lost are another input to health policy and priority setting. To allow 
comparisons of estimates reflecting data from 2004 and projected numbers of DALYs lost for three 
time periods (2008, 2015 and 2030), data are presented for major causes and countries are clustered 
by their level of income (Fig. 51). 
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Fig. 50. Total DALYs lost per 100 population in countries in the European Region, 2004 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: adapted from The global burden of disease: 2004 update (23). 
The data highlight several points. First, the overall number of DALYs lost is twice as high in low- 
and middle-income countries as in high-income countries in the European Region. This means that 
the former account for about two thirds of DALYs lost, but only just over half of the Region’s 
population. (See Annex 1 for classifications of countries by income in the European Region.) 
Besides the magnitude, the pattern of the disease burden differs by country income: low- and 
middle-income countries have high rates of diseases of the circulatory system followed by 
neuropsychiatric disorders, while high-income countries have high rates of neuropsychiatric 
disorders followed by malignant cancer and cardiovascular diseases. Cancer accounts for a similar 
number of DALYs in both groups. With the exception of an expected increase in infectious and 
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parasitic diseases and no change in cancer in low- and middle-income countries, the burden of 
disease will tend to decrease for all causes. Projections estimate that the levels of decrease will be 
smaller between 2008 and 2015 and larger between 2015 and 2030, particularly in high-income 
countries. 
Further, the total number of DALYs lost has been attributed to different leading risk factors in the 
European Region (Fig. 52). As a result, it is possible to identify the most important areas for 
developing cost-effective interventions to address, for example, nutrition, physical activity and 
addictive substances, mainly to reduce overweight and obesity, high cholesterol and high blood 
pressure, and alcohol and tobacco use. Further work to combine cost–effectiveness analysis with 
approaches to consider the distribution of services and benefits across the population, including 
particular subgroups, would also highlight equity issues (see the section on risk factors below). 
Although methods are constantly being refined, collating and analysing these types of data at the 
national, regional or global level can help to build up causal or pathway models for a given disease 
or set of diseases. Such models can provide insight into areas and levels for intervention and make it 
possible to identify actions that require intersectoral participation to reduce the overall disease 
burden, not just mortality. 
Box 6. Key messages – burden of disease 
• Mortality does not account for all the burden of disease; morbidity and disability also have their share. The 
use of DALYs as a tool for assessing health status beyond mortality provides another focus in the 
evaluation process. 
• The European Region’s total burden-of-disease distribution for 2004 shows a range of 10–28 estimated 
DALYs lost per 100 population. 
• The burden of disease is unevenly distributed within the Region: the overall number of DALYs lost is twice 
as high in low- and middle-income countries as in high-income countries. 
• DALYs have been attributed to leading risk factors in the European Region, making it possible to identify 
key areas for intervention, such as nutrition, physical activity and addictive substances, mainly to 
reduce overweight and obesity, high cholesterol and high blood pressure, and alcohol and tobacco use. 
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Fig. 51.Projected DALYs lost, 2008, 2015 and 2030 in countries in the European Region, by major cause and income level 
 
 
 
 
Source: The global burden of disease: 2004 update (23). 
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Fig. 52. Attributed DALYs lost by risk factor in the European Region, 2004 
 
Source: Global health risks: mortality and burden of disease attributable to selected major risks (24). 
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Risk factors 
An important element of disease prevention and control and health promotion is an understanding 
of the underlying causes, including risk factors, health system determinants and broader 
socioeconomic determinants (such as the social determinants of health) that shape the level and 
distribution of disease. For the major groups of diseases causing high mortality, morbidity and 
disability analysed in the previous sections, two main risk factors contribute to multiple disease 
outcomes and thus remain a priority to tackle: tobacco smoking and harmful alcohol consumption. 
From a European perspective, their prevalence and levels remain high across all populations, in 
spite of the knowledge and technology available to address both. 
Tobacco smoking 
The prevalence of regular tobacco smoking (the main component of tobacco use) in the European 
Region among the population aged 15 years and over has reached 27% on average (Fig. 53), 
according to data reported from 37 countries around 2008. In general, twice as many men smoke as 
women. Nevertheless, trends indicate that prevalence among women is increasing and beginning to 
converge with that among men (data not shown), particularly in countries with levels around or 
below the European average for men. 
Tobacco affordability, as determined by prices, can help to increase prevalence: higher smoking 
prevalence is associated with lower cigarette prices. Data from across Europe document that 
cigarette prices range from US$ 1 to over US$ 10 per pack (25). Addressing the aggressive 
marketing of tobacco products to young people, women and people with lower socioeconomic 
status requires equally aggressive and coordinated health policies, including those outlined in the 
WHO Framework Convention on Tobacco Control (26), ratified by 168 countries worldwide. In the 
European Region, 47 countries and the European Commission are Parties to the Convention. 
Alcohol consumption 
Alcohol consumption is another important factor that determines the frequency and severity of 
illness; it accounts for nearly 6.5% of all deaths in Europe (27). Estimated per capita alcohol 
consumption in the European Region remained almost unchanged over the past decade, with an 
average of 10.6 litres per person in 2007 (Fig. 54), according to data from 48 countries. 
Nevertheless, estimated average consumption levels vary significantly between countries, from 21 
litres to less than 0.5 litres per person. 
Not only the volume but also the type of alcohol consumed matters, as the higher the level of 
alcohol content consumed, the greater the negative health effects. Across the Region, the 
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consumption of beer, wine or spirits varies. Countries with a higher level of spirits consumption 
also have a higher burden of alcohol-related diseases. As with tobacco use, socioeconomic 
determinants and alcohol affordability shape excessive alcohol use and binge drinking – defined as 
heavy (>50 g alcohol) episodic weekly drinking –which has a well-documented negative impact on 
health (28). Data from individual countries show that the frequency of binge drinking tends to be 
inversely associated with the price of alcohol. Evidence from across Europe shows that an increase 
in diseases of the circulatory system and premature mortality can be attributed to very high 
consumption of alcohol and binge drinking patterns (29,30). For example, a recent study notes that 
when alcohol prices were reduced – similar to lifting other restrictions on access and use – alcohol-
related deaths among adults aged 40–69 years increased by 17–40% (31). According to information 
collected from across the European Region, successful policy approaches to reducing the 
deleterious effects of harmful alcohol consumption require a concerted effort involving and aligning 
several sectors, including the health sector, towards a common objective. 
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Fig. 53. Prevalence of regular smokers among the population aged 15 years and over in countries in the European Region, by sex, last reported data, 
2006–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
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Fig. 54. Average alcohol consumption per capita among the population aged 15 years and over in countries in the European Region, last reported 
data, 2006–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6). 
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Environmental factors 
Differential access or exposure to diverse environmental factors over the course of people’s lives is 
known to determine the occurrence of major health problems – including cardiovascular, respiratory 
and digestive diseases and neoplasms, as well as external causes of death – and to affect the severity 
of morbidity and disability. Various factors contribute directly or indirectly to shaping the health 
profile and disease burden of a population for good or ill:  
• access to clean water and good sanitation services; 
• poor housing conditions (such as dampness, poor indoor air quality and overcrowding); 
• road safety (such as road and vehicle conditions, use of protective equipment and speed 
limits); 
• poor air quality (from, for example, pollution with particulate matter, gases, toxic fumes and 
moulds);  
• work environments (including employment conditions and occupational risks); and 
• extreme climate conditions (whether heat or cold).  
Information on pathways from environmental factors to disease impact, and on measures of level 
and distribution, is vital to improve policies and monitor and evaluate their effects. 
A brief discussion of issues relating to monitoring and interpreting data on air quality, for example, 
hints at the impact such factors can have. Air quality is an important element for good human health 
and well-being, and extends beyond national borders. Yet air pollution continues to pose a 
significant threat to health in the European Region. As evidence on the health effects of air 
pollution mounts, countries across the Region are taking a greater interest in improving their 
monitoring procedures. As a result, data are increasingly available on concentrations of particulate 
matter – one of the basic air quality indicators – and its negative effects on health. 
With better information, policies and guidelines can be proposed, discussed, refined and 
implemented. For example, WHO (32) suggests a guideline value for particulate matter with an 
aerodynamic diameter smaller than 10 microns (PM10) at an average annual exposure of 20 µg/m3, 
as this is associated with potentially increased environmental health risk. Nevertheless, some 
negative health impacts on respiratory and circulatory system diseases have been observed in 
Europe at lower average exposure levels (10 µg/m3) (33). 
Air quality varies across the European Region, with the median value for country PM10 observed in 
2006–2009 at 26 µg/m3, which exceeds the WHO guideline value. Data indicate a fourfold gap in 
PM10exposure between countries, from a low of 14 µg/m3 to a high of 61 µg/m3 (Fig. 55). Of the 35 
countries with available data, 80% showed levels exceeding the standard threshold, while 15% had 
values at least double the standard level. Although specific to EU Member States, a recent report on 
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the impact of air pollution on population health indicates that air pollution accounts for on average 
eight months and, in the most polluted cities, more than two years of life lost (34). One should note 
that available country data from across Europe provide measurements from capitals or large cities 
(urban outdoor air pollution) and thus may overestimate the level of poorer air quality to which the 
entire population in a country is exposed. 
The data in this section show some of the most important risk factors, but give only a few examples 
of the complexity of interactions between a range of risk factors, disease processes and effects on 
health in Europe. These processes are further shaped by interactions with broader social 
determinants of health that can either mitigate or exacerbate inequalities in health, as discussed in 
the following sections. 
Box 7. Key messages – risk factors 
• Two of the main risk factors for major diseases are well known: tobacco smoking and harmful alcohol 
consumption. Various intersectoral interventions to modify them are available. 
• Although diverse tobacco control strategies have been implemented in many countries, smoking prevalence 
in the population aged 15 years and over reached 27% around 2008. An important factor that tends to 
affect smoking prevalence is affordability (cigarette prices). 
• According to WHO estimates, alcohol consumption accounts for nearly 6.5% of all deaths in Europe. As 
with tobacco, the affordability and accessibility of alcohol are important determinants of alcohol 
consumption, particularly the more seriously health-threatening binge drinking. 
• Differential access or exposure to diverse environmental factors over the course of a lifetime is a risk factor 
for major health problems. For example, air quality varies across the European Region, with the 
median value for country PM10 at 26 µg/m3, exceeding the WHO guideline value of 20 µg/m3. 
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Fig. 55. Average annual air concentration of PM10 in large cities in countries in the European Region, last reported data, 2006–2009 
 
 
Source: European Health for All database (6). 
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Social determinants and health inequalities 
Inequalities in health imply a difference or a disparity either in access to health-promoting 
opportunities and health services or in the distribution of disease burden (including morbidity, 
disability and mortality) and positive health in the context of well-being. These differences can 
reflect biological or genetic factors: for example, men are usually taller than women. Health 
inequities are differences in health that are unnecessary, avoidable, unfair and unjust (35). Health 
inequities are found across countries and between different groups of people in the same country. 
Evidence shows that factors driving health inequities are systematic and not distributed randomly. 
The WHO Commission on the Social Determinants of Health (CSDH) defines health equity as “the 
absence of unfair and avoidable or remediable differences in health among population groups 
defined socially, economically, demographically or geographically” (36). Numerous studies 
summarized by CSDH conclude that some of the variations in health across countries or within 
populations can be identified as health inequities. A proportion of these differences – from 25% to 
75% depending on the condition – is due not only to physical health factors but also increasingly to 
social factors that are amenable to policy. The CSDH report agrees that health inequities mostly 
point to policy failure, reflecting unfair or unjust disparities in daily living conditions and in access 
to power, resources and participation in society. 
As CSDH found, further supported by a recent report from the WHO Regional Office for Europe 
(37), the underlying causes of health inequities are complex. Moreover, inequalities often reflect 
systematic social, political, historical, economic and environmental factors; these interface with 
biological factors that are accumulated during a lifetime and often transferred across multiple 
generations. The term “social determinants” is often used as shorthand for all these factors, which 
are also known as the “causes of the causes” to indicate their fundamental influence on disease 
causation and distribution of health within a population or across countries. Moreover, the health 
system itself is a social determinant of health, as it can either improve or exacerbate existing health 
inequities. The concept encompasses the full set of social conditions in which people live and work, 
and has been summarized as “the social characteristics within which living takes place” (38). 
In this context, health inequities are an important priority in the European Region. They continue to 
increase and take many forms, from lack of access to health services to excess premature mortality, 
hampering social development and well-being. Prerequisites for tackling health inequities include 
being appropriately informed about their magnitude and distribution, both absolute and relative, and 
understanding how pathways from social determinants, other intermediary factors and health 
systems affect the disease burden, health and well-being. 
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Socioeconomic determinants 
Income level, employment status and education attained are among the most important social 
determinants of health, which in turn influence many other intermediary determinants. The gross 
domestic product (GDP) per capita is commonly used as a measure of income in a country in a 
given year, and is often positively correlated with the standard of living. 
Overall, the European Region is one of the wealthiest in the world, with an annual average per 
capita income of just under US$ 24 000 in 2009. Although increasing across the entire Region since 
1990, data from 50 of the 53 countries in the European Region indicate that per capita income levels 
vary widely: from just under US$ 700 to just over US$ 105 000 (Fig. 56). 
Nevertheless, improvements in income levels seen in the past decades are challenged by the current 
economic downturn, which is affecting most European countries and has many effects still to be 
assessed. Moreover, average per capita income does not provide insight into the evolving 
distribution of income within a country, such as whether income levels and distribution between 
subgroups in a population are becoming more or less equitable. 
The strong association between average per capita income and mortality levels is well established. 
Fig. 57 highlights one such example: premature mortality from diseases of the circulatory system. 
In countries with per capita income levels below US$ 20 000, mortality rates for diseases of the 
circulatory system exceed the European average, and tend to increase rapidly with lower income. 
This suggests an important health inequality that deserves greater attention in understanding the 
causal pathways and social processes that have led to or maintained such mortality rates. Another 
factor to consider is the extent to which such underlying causes can be considered health inequities. 
Further, decreasing income and increasing disease burden represent an important challenge because 
of the scale of the disease burden, and its negative impact on current and future economic 
development. 
Various mortality indicators show similar patterns of health inequalities across the EU. One is 
“amenable mortality”, which measures deaths that are premature and essentially avoidable by 
various known public health and health care interventions; this identifies inequity in health and can 
be an indicator of health systems’ performance. The approach to amenable mortality in the EU 
illustrates one way to document important health inequalities in the Region, consider associated 
factors and explore whether the differences are potentially avoidable. For example, analysis shows 
disposable income (the amount of money an individual or household has to spend or save: in other 
words, net income after paying all taxes or other mandated social charges) is associated with the 
occurrence of amenable mortality: the lower the disposable income, the higher the mortality. 
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Fig. 56. GDP per capita in countries in the European Region, 2009 
 
Source: European Health for All database (6). 
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Fig. 57. Premature mortality from diseases of the circulatory system and GDP per capita in 
countries in the European Region, last reported data, 2006–2009 
 
Source: European Health for All database (6). 
Approaches that enable health inequalities to be visualized can provide further insights. In 2007 the 
WHO Regional Office for Europe undertook a project with the European Commission called 
“Inequalities in health system performance and social determinants in Europe – tools for assessment 
and information sharing” (39), which developed a set of interactive atlases to improve the evidence 
base for identifying and analysing social inequalities in health (39) (see Box 10 in Chapter 2). 
Rather than aggregated data at the national level, the project looked at the data from the 281 
subnational regions of the EU. Mapping data on amenable mortality (from all causes) for each of 
these regions shows a geographical gradient, with higher death rates in the eastern and north-
western parts of the EU, although some regions in other areas also have high mortality rates 
(Fig. 58). The superimposed hatching in Fig. 58 marks the EU regions in the poorest quintile (the 
20% of the 281 regions with the lowest per capita income). This additional layer tends to validate 
the association with higher avoidable mortality. Nevertheless, some poorer regions have relatively 
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low mortality levels. This requires additional investigation and research to identify other potential 
explanations. For example, what characteristics of these regions enable them to mitigate the effects 
of being relatively poorer, and to achieve lower amenable mortality? Are these characteristics 
related to policies and their effective implementation, involving, for example, a range of 
stakeholders, intersectoral action or effective public health functions? An understanding of the 
context, good practices and lessons learned could allow new policy options and strategies to be 
adapted and introduced in other resource-poor settings. 
Fig. 58. All-cause amenable mortality by subnational regions of the EU and neighbouring countries, 
around 2006 
 
Source: Inequalities in health system performance and social determinants in Europe [web site] (39). 
The most recent report of the Health Behaviour in School-aged Children (HBSC) study (40) offers 
another example of how social determinants can shape the distribution of health. This multicountry 
study included 15-year-olds’ assessment of their own health status (as excellent, very good, good, 
fair or poor) and analysed those reporting fair or poor health by sex, by family affluence and across 
countries (Fig. 59). While nearly 20% of 15-year-olds rated their health as fair or poor, girls 
reported significantly lower levels of self-rated health than boys (on average, 23% and 14%, 
respectively), a consistent difference in all participating countries. In addition, 15-year-olds in 
affluent families were 20% less likely to report fair or poor health. 
Regions in the 
poorest quintile 
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Fig. 59. Self-rated health of 15-year-olds in countries in the European Region, by sex and family affluence, 2009/2010 
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Source: Currie et al. (40). 
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The overall results point out that perceived relative differences in wealth are associated with self-
reported health across Europe, as well as, most likely, gender norms and roles. This draws attention 
to the apparent concentration of lower levels of self-reported health among adolescent girls in less 
affluent families. The importance of and challenges in measuring self-reported health within the 
context of well-being are further addressed in Chapter 3. 
Unemployment is an indicator that directly reflects the economic opportunities and ability of a 
country to incorporate its potential workforce, and an important social determinant of health. 
During the recent economic downturn, unemployment increased to an average level of 8.7% of the 
economically active population in the European Region in 2009. This followed a decade of 
decreasing unemployment levels across the Region. At the country level, the highest unemployment 
level across 45 countries in the Region is 35 times the lowest level (Fig. 60). 
Acute economic changes, measured by the unemployment-rate change, provide further insight into 
the potential impact on the health and well-being of populations, and add to the discussion on 
potential contributing factors to external causes of mortality (see Fig. 38). For example, an increase 
in unemployment of over 3% in a relatively short time has been associated with a nearly 5% 
increase in suicide and self-inflicted injuries among people younger than 65 years (41). Between 
2007 and 2009, the average unemployment rate in the European Region increased by nearly 1%, 
with significant variation across the 38 countries reporting data (Fig. 60). Although unemployment 
is a blunt indicator, based on recent trends and synthesized evidence, countries with increases of 3% 
and more are at potentially higher risk of increased mortality from self-harm. 
Rising unemployment threatens to pose additional challenges to health systems, including ensuring 
appropriate services for more vulnerable or poorer population groups. The increased frequency of 
some health problems may result from additional stress, the adoption of unhealthy behaviours (such 
as tobacco smoking and abuse of alcohol and other substances) and inadequate health care resulting 
from overburdened services and delays in seeking care. Moreover, people who want to work yet 
cannot find it are also at risk of being excluded from a range of other social processes, depending on 
the context. Regular monitoring of these and other trends should be encouraged, using a whole-of-
the-gradient approach, in which the entire population is monitored, not just vulnerable groups. 
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Fig. 60. Rate of and change in unemployment among the economically active population in countries in the European Region, last reported data, 
2007–2009 
 
Source: European Health for All database (6). 
Country
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The health determinants discussed and ways to identify health inequities are only illustrative, given 
the wide range of potential social determinants of health. Although policy options and actions to 
reduce health inequities are beyond the scope of this report, systematic and coordinated actions are 
clearly required, ranging from prioritizing the needs of people with vulnerabilities to addressing the 
well-being of future populations. Such actions can be categorized as promoting health across all 
population groups in relation to need, and improving the social determinants of health. Actions for 
the latter usually lie outside the specific remit of the health sector or health system, but the health 
sector can champion and contribute significantly to aligned efforts. 
Environmental determinants 
The environment represents another important health determinant, and the underlying issues are 
similar to the social determinants of health. Recent assessments on the contribution of 
environmental factors to health have estimated that they may be responsible for between 13% and 
20% of the burden of disease in Europe, depending on their mortality pattern classification, such as 
population-specific levels of child and adult mortality strata (42). 
The availability of water in human living spaces, for both consumption and hygiene, is essential. 
Overall, access to water in the European Region is among the best in the world. Some issues still 
arise around the quality of water, however, particularly contamination by pathogens and chemical 
elements, which are caused by leakage from old pipes, breaks in services or lack of high-quality 
water protection and chlorination. Data on access to water (the population connected to a water 
supply system) and sanitation (the population connected to a sewage system or a septic tank or with 
other means of hygienic sewage disposal) in urban and rural settings were analysed for changes 
between 1990 and 2008. Overall, the share of the population with access to water in the Region in 
2008 was 96% in urban areas, but 75% in rural areas (Fig. 61). Differences between countries range 
from nearly 100% access in both urban and rural areas to some larger gaps between areas in eastern 
countries in the Region. 
Inadequate management of human excreta disposal may lead to increased disease risk. In the 
European Region, 97% of the urban population has improved sanitary excreta disposal, in contrast 
to 89% in rural areas. 
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Fig. 61. Access to water and sanitation in urban and rural areas in the European Region, 1990 and 2008 
 
 
Source: European Health for All database (6). 
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The lack of these services in some parts of the Region has led to increased exposure to pathogens, 
some causing diseases with high epidemic potential, such as cholera, shigellosis, haemolytic 
uraemic syndrome, cryptosporidiosis and giardiasis. These infectious diseases have taken their toll, 
with increased numbers of cases, including some requiring hospitalization, resulting in direct and 
indirect economic loss. Protection of water resources, further investment in public services and 
good planning of urbanization of the population will help to address access limitations. 
Various socioeconomic, demographic and geographical conditions determine environmental 
exposures and produce important health inequalities, many of which can be considered to be 
inequities. The WHO Regional Office for Europe recently assessed the impact of environmental 
factors on health inequalities in the European Region (43). Key factors include the availability of 
water and sanitation, housing conditions and the broader environment, including outdoor and indoor 
air quality and noise. According to the report, socioeconomically determined health inequalities 
related to noise, second-hand tobacco exposure and housing quality have the clearest effects and 
show some of the strongest patterns of inequalities at different geographical levels. In addition, 
gender inequalities are more strongly associated with external causes of injury and poisoning, where 
male fatality rates are often three or more times those for females. 
Health systems as health determinants 
An effective health system is a prerequisite for responding to the changing epidemiological 
situation and health needs and demands of the population. Some key expectations include disease 
prevention and control, mitigation of disease consequences (including disability) and promoting 
healthy behaviours and lifestyles, with comprehensive approaches to deal with different health 
problems throughout the life-course. To achieve its objectives – improving the level of health 
(“goodness”) and its distribution in a population (“fairness”) – the health system needs: 
• to be well organized and functioning, including providing leadership and accountability; 
• to ensure financing; 
• to maintain its infrastructure, including the workforce; and 
• to provide high-quality services.  
In times of resource constraints, the balance of appropriate resources – financial, human and 
material – is essential. The 2009 European health report (2) focused on the importance of 
strengthening health systems across Europe; this is not the main subject of this report (see Box 25 
on recent work on health systems and the contribution to overall well-being). Nevertheless, given 
the recent economic downturn, this section highlights health care financing and protection from 
financially catastrophic expenditure (44) as a critical aspect of the way health systems can either 
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mitigate (for example, by being more progressive in financing) or exacerbate (for example, by 
further widening inequalities, such as those in access to care) economic shocks. At present, 
measures of the incidence and magnitude of households’ direct payments for health care form the 
basis of metrics for assessing financial protection and comparing health systems (45). 
Overall, a country’s investment in health comprises the government’s response to the needs of the 
population (public) and households’ use of resources (private). Total health expenditure shows 
countries’ efforts at health investment and is usually presented as a percentage of GDP; the average 
level for the European Region was 8.5% in 2009. Nevertheless, levels of investment in health vary 
significantly between countries across the European Region, ranging from a high of 12% to a low of 
2% (data not shown). Moreover, what matters is not only the level of spending but also the 
efficiency and equity of the use of resources to increase overall levels of health and improve the 
distribution of health. 
In an economic crisis, when many people and households have less money, they tend to delay 
seeking health care, particularly when they must pay for services directly. Such payments are called 
private, out-of-pocket (OOP) expenditure. Particular concern focuses on catastrophic health 
expenditures, which threaten to impoverish households in countries where health systems rely 
heavily on household contributions. In the European Region, this is particularly relevant in 
countries where the rising costs of goods and services have weakened the purchasing power of 
many families. 
On average, OOP expenditure made up 23% of total health expenditure in the European Region in 
2009 (Fig. 62). Nevertheless, this proportion varies widely between countries, ranging from 5.7% to 
79.5%: a fourteenfold gap. OOP expenditure remains the main source for payments (about 50% or 
more) in about 10 countries in the Region, while in other pooled prepayment mechanisms (for 
example, through government taxes or health insurance funds) are the main source of financing and 
expenditure. Evidence from around the world suggests that reaching two targets could considerably 
reduce the incidence of financial catastrophe for households: that OOP expenditure comprise no 
more than 15–20% of total health expenditure and that government expenditure on health comprise 
at least 5–6% of GDP (45). 
The paradox is, however, that countries with the highest private OOP expenditure are also less 
economically favoured (Fig. 63) and those with smaller government contributions to health 
expenditure. Although these circumstances make expanding the financial space to increase the 
public share of health expenditure more difficult, WHO recently outlined policy options and 
strategies that countries with different economic levels can consider as they explore ways to ensure 
sustainable and more equitable financing for health (45). 
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Fig. 62. OOP expenditure as a proportion of total health expenditure in the countries in the European Region, 2009 
 
 
Source: European Health for All database (6). 
Country
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Fig. 63. OOP expenditure as a proportion of total health expenditure and GDP per capita in 
countries in the European Region, 2009 
 
Source: European Health for All database (6). 
Box 8. Key messages – social determinants and health inequalities 
• Health inequalities are a major concern in the European Region, as they continue to increase. 
• Social determinants of health include socioeconomic, demographic, environmental and cultural factors, 
along with the health system itself. They encompass the full set of social conditions in which people 
live and work. 
• Income level, employment and education are among the most important socioeconomic health 
determinants. Although increasing since 1990, income levels in the European Region are still highly 
inequitable. 
• Environmental factors are another major health determinant; key elements include the availability of water 
and sanitation, housing conditions and the broader environment, including outdoor and indoor air 
quality and noise. Different socioeconomic, demographic and geographical conditions determine 
environmental exposures, producing important health inequalities. 
• Health care financing is critical in determining how health systems can either mitigate or exacerbate 
economic shocks experienced by households. 
Chapter 1 outlines the health status and trends in Europe based on the most up-to-date data from 
Member States, highlighting where we as the Region stand, and describes the evolving context in 
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which the Health 2020 policy will be implemented. Agreeing on the goals and priorities for the 
WHO European Region– what we are aiming for – is a first step towards establishing achievable 
targets and monitoring progress at the regional level; this is the subject of Chapter 2. 
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2. What we are aiming for: European targets for health and well-being 
Through an intense process of consultation, the work of several expert groups and endorsement by 
the sixty-second session of the WHO Regional Committee for Europe, Health 2020 arrived at six 
goals (overarching targets), which it aims to achieve by 2020. These include a reduction in 
premature mortality, increases in life expectancy, a reduction in inequalities, and the enhancement 
of well-being, universal coverage and demonstrated target-setting efforts at the country level. The 
WHO Regional Director for Europe will report progress towards achieving the targets as regional 
averages, but monitoring of indicators at the country level is necessary to inform such regional 
targets. For this purpose, health information that is routinely collected by countries should be used 
to the greatest possible extent and the collection of new data should be avoided where possible. 
Every effort will be made to ensure that the targets and indicators used will be fully aligned with 
global target-setting work.  
In the context of Health 2020 a target is defined as “a desired goal”. The desired outcome is health 
improvement, and targets are drafted in terms of, for example, reductions in mortality or morbidity. 
In addition, where improvements in health outcomes can be linked to processes or outputs with 
adequate scientific evidence, targets can also be legitimately drafted in terms of a process or an 
output, such as increases in public health expenditure or the introduction and enforcement of 
legislation fostering public health objectives.  
One of the difficulties is to find the appropriate mix of indicators to reflect progress towards 
strategic goals and targets in a valid and reliable way. In monitoring health policy, the time lags 
between interventions and their impact on health status, as well as the difficulties of attributing an 
outcome to specific interventions, have usually encouraged the use of process or output indicators 
in addition to outcome indicators. The coherence of process, output and outcome indicators lies at 
the centre of measuring progress towards agreed goals and their associated targets. All need to be 
measured as long as the causal link cannot be ascertained. All need to evolve dynamically as the 
link is being tested in a wide range of contexts. For example, when process indicators improve, is 
there a measurable improvement in outcome indicators? 
Thinking about the role of targets in Health 2020 needs to consider the principles of performance 
measurement and accountability. In the case of Health 2020, accountability can only exercised 
collectively by and between Member States. If people in each country are the ultimate principals in 
a complex accountability chain, we as a Region should ask how well policy and systems serve the 
population. This chapter sets out the process that led to agreement on the goals – the overarching 
targets aligned to the Health 2020 policy – and proposes more specific target areas and indicators to 
assess progress at the European level (Box 9).  
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Box 9. Terminology for target setting 
A policy is an agreement on goals and objectives, the priorities between those objectives and the main 
directions for achieving them.  
A goal refers to the long-range aims of society and is usually expressed in rather general terms.  
A strategy refers to the broad lines of action for achieving the goals and objectives.  
A target is an intermediate result towards the achievement of goals and objectives; it is more specific, has a 
time horizon and is frequently, though not always, quantified.  
An indicator is a measurement that helps us to understand where we are, where we are going and how far we 
are from the target. Targets and indicators are sometimes confused. Targets should be set before indicators 
are selected to monitor progress towards a target.  
Source: adapted from Ritsatakis (46).  
A baseline is provided for several indicators, reflecting the most recent data reported to the WHO 
Regional Office for Europe from across the Region’s 53 Member States. The chapter concludes 
with a framework for the monitoring of targets and indicators for Health 2020 that will be refined in 
consultation with Member States.  
Previous target-setting and monitoring experiences 
The use of targets 
Historically targets were first suggested in the European Region as part of the first common health 
policy: the European strategy for attaining health for all. The policy called for the formulation of 
specific regional targets to support the implementation of the strategy. Aptly described as a 
“wonderful blend of today’s realities and tomorrow’s dreams” (47), the 1984 WHO Regional 
Committee for Europe, meeting in Copenhagen, Denmark, adopted 38 specific regional targets and 
65 indicators to monitor and assess progress at the regional level. The European Health for All 
policy and targets were updated in 1991 and the Regional Committee adopted a renewed policy, 
“HEALTH21 – Health for All in the 21st century”, in 1998.  
Health for All 
In 1981 WHO published its global strategy for Health for All by the year 2000 (48); the WHO 
Director-General at the time, Dr Halfdan Mahler, stated that this was “not a separate ‘WHO 
strategy’, but rather an expression of individual and collective national responsibility, fully 
supported by WHO”. Soon afterwards, WHO regional offices started developing regional health 
targets. The WHO Regional Office for Europe led the way by producing the most comprehensive 
list in 1984.  
The then 32 Member States in the WHO European Region debated the new European health policy, 
Health for All by the year 2000, and regional targets were aligned to the new policy. The 
formulation of European targets was a major undertaking, with the staff of the Regional Office 
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working with more than 250 experts from across Europe, going through more than 20 drafts and a 
complex consultative process with Member States, over about three years (49). The result was 82 
targets presented for consideration to the Regional Committee for Europe, which unanimously 
adopted a reduced set of 38 1984. Then the new European health policy was published (50).  
The policy and accompanying targets stimulated European Member States to reassess their health 
strategies and, in many cases, to set their own targets for health improvement. The original 38 
targets addressed health goals (targets 1–12), strategies to reach them (targets 13–21) and sustained 
political, managerial, financial support and mobilization (targets 22–38) to inspire and guide (50). 
This was the first time the European Region had had a distinct health policy with goals, strategies 
and targets outlined (see Box 9).  
In 1991 the 38 targets were revised to reflect the changes in the Region since the mid-1980s. The 
intention was to provide a contemporary understanding of the problems involved in target setting 
and in approaches to achieving them. The six major themes of the first target set were retained 
(promoting equity in health, community participation, health promotion and disease prevention, 
reorientation of the health system towards primary health care and collaboration for health across 
sectors), and an explicit concern with ethics and inequalities across different population groups was 
added. The Regional Office supported the implementation of the targets by aligning its budgets and 
programmatic activities with it and responding to Member States’ requests.  
HEALTH21 – a more focused strategy 
The major political, economic and social changes in the Region during the 1990s transformed the 
European landscape. One result was a dramatic increase in the number of European Member States 
to more than 50 by the end of the decade. Unsurprisingly, the WHO Regional Office for Europe 
revisited its European health policy and regional targets. In 1999, it published the HEALTH21 policy 
document with a new set of “21 targets for the 21st century”, identifying two main aims, three basic 
values, and four main strategies (4). The new policy made a first step towards approaches to 
monitor compliance, as it noted how each target could be achieved and suggested areas for 
formulating indicators. In addition, HEALTH21 was aligned with Agenda 21 on sustainable 
development. In practice, the focus remained on the construction of targets at the country and local 
level, with no regional reporting.  
In 2005, the Regional Office published an update of the European health policy that reviewed and 
affirmed HEALTH21: “incorporat[ing] the knowledge and experiences that have accumulated since” 
1998 (3). The publication (3) noted that the HEALTH21 targets continue to provide a regional 
framework – “the essence of the regional policy” – yet emphasized that the 21 targets provided an 
inspiration “for the construction of targets at the country and local levels”.  
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Some lessons learned about target setting 
The WHO European Region has about 30 years of experience in setting targets as part of regional 
health policies and strategies, albeit in the context of a Europe that has changed dramatically. Dr Jo 
E. Asvall, WHO Regional Director for Europe between1985 and 1990 (51), summarized targets’ 
functions: 
These targets and indicators made the European Health for All policy sharper and provided a model 
for the Region as a whole, which countries could adapt to their own contexts. They also provided 
public health advocates, professionals, academics and government decision-makers at grassroots with 
a lever to push for Health for All within countries.  
Several lessons have been learned over the decades.  
• A broad consensus needs to be developed among stakeholders. The development of a health 
policy at the political level requires both recognition of the need for action and political will 
to implement it.  
• Targets need to be limited to a manageable number. WHO’s original 38 were widely agreed 
to be too many, but so perhaps were the subsequent 21 programme. Most national and 
regional programmes have focused on 5–10.  
• Any plan should be based on evidence of effectiveness. Although health promotion is 
supported by more evidence of effectiveness than is often thought, much remains poorly 
evaluated and it often dependent heavily on context.  
• To be achieved, targets need to be linked to resources.  
• Once a target-based strategy is agreed, technical challenges remain. Target setting requires an 
understanding of the current pattern of health in a population, including determinants, and 
projections based on the best available models (52).  
While the Health for All targets (50) were not generally quantified and were meant to be achieved 
at the country level, not the regional, those of HEALTH21 (4) tended to be too specific and – with 
hindsight – to a large extent unachievable.  
Health for All database 
The Health for All database (6) is the basis for monitoring and reporting on the European targets 
and indicators. It has evolved to cover 53 countries and is widely used across the Region. The 
database includes several hundred indicators, and health statistics covering basic demographics, 
health status, health determinants and risk factors, and health care resources, utilization and 
expenditure. These data are compiled from various sources, inform the interactive atlases of health 
in the European Region (20), and are updated twice a year.  
In 2012, the WHO Regional Office for Europe launched a new annual publication reporting on core 
indicators from the Health for All database. It will launch a new web portal in 2013, which permits 
users to access and analyse all databases simultaneously from one location. Additional added value 
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to users will include new data visualization tools, including dashboards and the interactive atlases 
(Box 10).  
Box 10. Interactive atlases – visualization of EUROSTAT databases 
Publicly available socioeconomic and health-related indicators from across European databases – particularly 
those of EUROSTAT (the statistical office of the EU) – were used to produce interactive atlases. The NUTS 
2 regions (the second level of regions in the Nomenclature of Units for Territorial Statistics used in the EU) 
are the main geographical units of analysis. Variables displayed in maps, graphs and tables represent more 
than 600 individual indicators. To analyse and display data, the WHO Regional Office for Europe developed 
the following interactive atlases: a correlation map atlas, atlases of social inequalities and a regional 
comparison atlas (20).  
The atlases aim not only to provide more visibility to the subnational patterns of health and their 
determinants but also to analyse how such an integrated information system and its underlying data can 
inform policy across European countries. For example, the atlases of social inequalities allow visualization 
of the difference between a target value and the value in a region or group of regions. The target value is the 
population-weighted average of the most advantaged quintile of the population with available data, and is 
considered an achievable goal. Differences between the target and the individual region are visualized as 
absolute differences (area target differences) and as relative differences (area target ratios). The amenable 
mortality atlases show an example of the socioeconomic variable of disposable income, net purchasing 
power standard based on final consumption per inhabitant.  
Health 2020 targets – building on and updating Health for All and 
HEALTH21 in a contemporary context 
Consultation on and endorsement of the Health 2020 targets 
At its sixty-first session in September 2011 in Baku, Azerbaijan, the WHO Regional Committee for 
Europe endorsed proposals that Health 2020 would: 
• set out an action framework to accelerate attainment of better health and well-being for all;  
• be adaptable to the different realities that make up the Region; and  
• have regional targets for achievement by 2020.  
The process of target setting was informed by previous efforts, detailed participatory discussion and 
written consultation, and the results approved by WHO governing bodies at each stage. At its sixty-
second session in September 2012 in Malta, the Regional Committee endorsed the Health 2020 
policy, its overarching targets and the need for specific targets and indicators to monitor 
implementation by 2020 (53) (Box 11).  
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monitoring and reporting was that existing, available health information should be used as much as 
possible, and that the targets would be regional, not national, with progress reported at the European 
level. Representatives of Member State delegations and nongovernmental organizations alike 
congratulated the WHO Regional Office for Europe on its efforts, and underlined the need to ensure 
that targets and indicators were specific, measurable, achievable, relevant and timely (SMART).  
The Regional Office will reconvene the expert group that had guided the process and, after further 
broad consultation, submit the final list of indicators to the SCRC and then the Regional Committee 
for adoption in 2013. The key debates and decisions within these processes are described further in 
this chapter.  
Formulating targets – general principles and specific criteria 
Targets have often been associated with reductionist views of system behaviour and performance, 
as well as mechanisms of hierarchical thinking and control. Yet the present literature on health 
systems increasingly considers these to be systems characterized by complexity and uncertainty; 
thus, targets may help to clarify expectations, motivate performance and improve accountability in 
this context. Moreover, the concept of “collective benchmarking” (54) provides a participatory 
process for the setting of goals and targets, in which the parties are accountable to one another, to 
facilitate overall improvement. Box 12 summarizes both the strengths of targets and limitations on 
their usefulness.  
Box 12. Strengths and limitations of targets 
Strengths Limitations 
Targets are a concrete way to express policy 
and focus direction, including raising 
awareness and facilitating political and 
organizational support (for example, the 
MDGs).  
Targets are difficult to align with strategy.  
They reflect a scientific view on the future, in 
terms of achievable improvements in 
population health.  
There is a risk that priority will be given to 
targets that can be measured easily (“what 
can be measured gets done”). 
They provide a learning experience for 
stakeholders.  
They may be liable to bureaucratic capture – 
elements of the organizational bureaucracy 
justify their existence in terms of a target.  
They are seen as a tool for strengthening 
accountability and communication.  
They are subject to the law of diminishing 
returns – achieving the last few percentage 
points of a target may be very resource-
demanding. 
They provide a map for partners.   They may be associated with “gaming” – 
managing the target rather than the task.  
They serve as reference points for day-to-day 
action.  
If too numerous or complex, they may be 
seen as burdensome and demotivating.  
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They provide motivation for action, creating 
a virtuous cycle.  
They are often expressed in terms of averages 
(as with the MDGs), thus hiding distributive 
or equity issues that will be fundamental for 
Health 2020. 
Targets should be adaptable and dynamically assessed. In the context of policy implementation, 
targets are a heuristic that gives a concrete direction useful in assessing and adjusting activities 
along the way. A crucial consideration is the availability of data. Monitoring progress towards 
health targets depends on the availability of comparable data of reasonable quality and reliability. In 
practice this is often a key constraint. Data availability is one criterion for either regional or country 
indicators to monitor Health 2020 targets. Even so, experience in the European Region has shown 
that setting targets and selecting indicators can be a huge motivating and innovating factor for 
countries to strengthen and/or expand data collection and incorporate reporting within national 
routine information systems. This includes stimulating the use of new and existing data to inform 
public health policy, including wider government policies promoting health. For some countries, 
this has catalysed the inclusion, analysis and use of data that had not previously existed at the 
national level.  
These issues were considered by the internal and external steering groups for Health 2020, and in 
the Regional Office’s wider consultations with Member States and experts. Clear guiding principles 
and criteria were set for the use of targets within Health 2020. From the start, Member States agreed 
that targets would be set at European rather than country level, leading to reporting of regional 
averages. Hence targets should be both relevant for the whole Region and important for every 
Member State. A European-level target is meant to inspire and to promote learning, solidarity and 
engagement – particularly, yet not only, on cross-border issues. At the same time, Member States 
are encouraged to develop their own national targets and strategies for action; the specific context 
should be the development of national policies for health.  
Moreover, a good balance had to be struck between different types of targets, given the themes of 
Health 2020: a mixture of outcomes, determinants, risk factors and processes; input targets on, for 
example, investment, capacity and resources; and some looking at distribution within a country or 
across countries to address health inequalities – gradients and gaps, relative and absolute – and 
promoting “levelling up” rather than being satisfied with regression to the mean.  
Another important consideration was to be realistic and parsimonious, yet not simplistic: for 
example, by creating a set of 5–10 understandable and measurable targets, possibly with 
quantitative and qualitative measures. Consultation with Member States and governing bodies 
confirmed the need for mechanisms for accountability.  
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Further, the targets had to refer explicitly to existing global frameworks, conventions, targets and 
strategies to which all countries had agreed, or signed, in the case of conventions and treaties. In the 
contemporary context, it was important to be in line with not only the MDGs but also new global 
targets on NCDs, among other global and regional issues.  
SMART targets are more likely to be accomplished than general goals. Targets must be clearly 
expressed and unambiguous. To arrive at measureable targets, concrete criteria for measuring 
progress must be established. For targets to be achievable, they must be realistic and set against a 
defined time scale: a time frame, preferably with deadlines, maintains momentum and increases 
targets’ use to catalyse collective action. Targets are considered relevant when they represent 
objectives to which a policy can contribute. Again, although a heuristic, every target should 
represent real progress with qualitative or quantitative measures. In fact, the SMART criteria should 
apply to both qualitative and quantitative targets.  
Formulation of specific targets for Health 2020 
Process 
The process of target and indicator setting is complex and previous experience with the Health for 
All approach in the 1980s and 1990s – and more recently with setting goals for the MDGs – showed 
that a well-organized mechanism was needed to achieve SMART outcomes. It needed to include a 
monitoring framework and structured reporting, as well as elements of interpretation of the 
indicators and what achievement of SMART targets would mean for the European Region. The 
process had to be participatory, but not too complex and cumbersome. The SCRC proposed forming 
a small working group on targets and indicators, composed of the following members: 
• experts from Member States (represented in the SCRC and the Forum of High-level 
Government Officials) with expertise in the subject areas and health information;  
• senior staff of the WHO Regional Office for Europe; and 
• Regional Office staff with experience and expertise in target setting and health information.  
Member States contributed to the technical deliberations, working closely with the WHO 
Secretariat, as proposed by the SCRC in May 2011. Representatives of the following Member 
States were nominated for this working group: Andorra (previous SCRC chair), Poland, Sweden 
(subsequent SCRC chair), the former Yugoslav Republic of Macedonia (former SCRC Chair), 
Turkey, Ukraine and the United Kingdom. A representative of a Member State (Sweden) with 
extensive experience in this area and the WHO Regional Director for Europe co-chaired the group. 
The group held meetings via video or teleconferencing every 1–2 months and face to face in 
connection with SCRC and Regional Committee meetings, with terms of reference spelled out in 
Box 13.  
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Box 13. The SCRC working group on targets and indicators 
The SCRC working group on targets and indicators agreed on its terms of reference during its first 
teleconference: 
• to finalize the modus operandi of the Working Group, including a roadmap;  
• to summarize the results of the discussions within the SCRC and WHO Regional Office for Europe in 
relation to Health 2020 targets and to examine previous target-setting exercises;  
• to agree on the technical methodologies used for setting targets and indicators, placing particular emphasis 
on recommending a process and methodology for the development of qualitative targets;  
• to identify salient issues for presentation to the Regional Committee;  
• to establish two high-level targets for each major area, and to discuss and propose up to two subtargets for 
each high-level target;  
• to research and propose the indicator(s) for each target that follow the principles agreed on and for which 
information is available;  
• to accompany the consultation with Member States, to be coordinated by the Regional Office;  
• to propose and finalize the targets to be presented to the sixty-second session of the Regional Committee in 
connection with the finalized Health 2020 policy.  
The group co-opted other experts as required, and maintained close links with the groups conducting studies 
to support the development of Health 2020, particularly the task group on measurements and targets involved 
in the review of social determinants of health and the health divide in Europe. At each meeting, the working 
group made clear recommendations to narrow the list of potential targets and indicators in line with the three 
broad areas initially identified as part of Health 2020: 
• the burden of disease and risk factors;  
• healthy people, well-being and determinants;  
• processes including governance and health systems, for wider consultation (47).  
The Regional Office Secretariat collated inputs and recommendations on the process, as well as potential 
targets for inclusion, for the various consultations with Member States.  
Health 2020 targets 
As mentioned, the Regional Committee adopted the text with the six overarching targets and agreed 
on the development of indicators to assess the success of the implementation of Health 2020 across 
Europe. The targets have the advantage of being inextricably linked to the strategic objectives and 
policy priorities of Health 2020. The rationale for choosing them was that they either are in line 
with contemporary global target-setting efforts, for example, in the area of NCDs, or extend and 
update previous European target-setting strategies and approaches acknowledged or agreed by 
European Member States.  
Here are the overarching targets. 
1. Reduce premature mortality in Europe by 2020. 
2. Increase life expectancy in Europe. 
3. Reduce inequities in health in Europe. 
4. Enhance the well-being of the European population. 
5. Provide universal coverage in Europe. 
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6. Establish national targets set by Member States.  
Table 1 shows the correlations between the areas addressed by the Health 2020 targets and the 
Health for All and HEALTH21 targets.  
Although progress on the overarching targets will be reported at the European Regional level, most 
actions will occur at the country level. The sixth overarching target makes this explicit, and reflects 
many European countries’ inclusion of target setting in their national health policies (Box 14).  
Box 14. Case study: targets in action in Austria (55) 
Through an extensive and broad process of consultation during 2011 and 2012 the Austrian Federal Ministry 
of Health arrived at 10 national framework health targets. A committee was set up to develop the targets, 
comprising representatives of almost 40 public authorities at the federal, regional and local levels (covering 
different political sectors), social insurance and social partners; experts on the health care system and health 
care professionals; and representatives of institutions of the health and social care system, and of patients, 
children and adolescents, elderly people and socioeconomically disadvantaged people.  
Interested citizens were able to participate in the process by using an internet platform that allowed them to 
provide input at the start and feedback on the draft targets at the end of the process. Two large conferences – 
to start the process in May 2011 and to present the draft health targets in May 2012 – were organized to 
involve a wider group of health experts and members of the public.  
The targets cover a wide span: from a healthy environment and equity to health literacy, from social 
cohesion and healthy lifestyles to health care, and from healthy childhood and nutrition to promotion of 
psychosocial health. The overall target is to increase healthy life expectancy by 2 years within the next 20 
years. Following approval by the Federal Health Commission and a resolution by the Council of Ministers in 
July 2012, Austria is now identifying suitable indicators for each of the 10 targets and setting up a binding 
plan for implementation and health reporting. For implementation and evaluation, the same cross-sectoral 
group of political and societal institutions and stakeholders will be nominated as a target monitoring board.  
 
© BundesministeriumfürGesundheit. 
 
 98 
 
Table 1. The areas addressed by the overarching targets of Health 2020 and previous European targets  
Health 2020 
target area 
Health 2020 
overarching target 
Equivalent targets 
Health for All (50) HEALTH21 (4)
Burden of 
disease and 
risk factors 
1. Reduce premature 
mortality in Europe by 
2020 
No direct equivalent but indirect ones through targets 
on reduction of infant, child and maternal mortality 
and healthy ageing 
Premature mortality targets under various 
headings, including young people, road safety, 
communicable diseases and NCDs 
Healthy 
people,  
well-being 
and 
determinants 
2. Increase life 
expectancy in Europe 
“By the year 2000 life expectancy at birth in the 
Region should be at least 75 years and there should 
be a sustained and continuing improvement in the 
health of all people aged 65 years and over” 
“By the year 2020 … the gap in life 
expectancy between the third of European 
countries with the highest and the third 
ofcountries with the lowest life expectancy 
levels should be reduced by at least 30%” 
3. Reduce inequities in 
health in Europe (social 
determinants target) 
“By the year 2000 the actual differences in health 
status between countries and between groups within 
countries should be reduced by at least 25%; people 
with disabilities should be able to lead socially, 
economically and mentally fulfilling lives” 
“By the year 2020 … the gap in life 
expectancy between socioeconomic groups 
should be reduced by at least 25%; the values 
for major indicators of morbidity, disability 
and mortality in groups across the 
socioeconomic gradient should be more 
equitably distributed” 
4. Enhance the well-being 
of the European 
population (to be further 
elaborated during 
2012/2013) 
“By the year 2000, all people should have the 
opportunity to develop and use their own health 
potential in order to lead socially, economically and 
mentally fulfilling lives” 
“By the year 2020, people’s psychosocial well-
being should be improved” 
Processes, 
governance 
and health 
systems 
5. Provide universal 
coverage in Europe 
Formulated as access to care, particularly primary 
health care, without financial burden to households 
“By the year 2010 funding systems for health 
care [should] guarantee universal coverage, 
solidarity and sustainability” 
6. Establish national 
targets set by Member 
States
Support provided to target setting and health 
information in countries, including indicators and 
adequate information systems at the country level 
A high proportion of targets also formulated 
for national achievement 
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Identifying ways to set target levels and indicators 
Once target areas are agreed, the next step is to identify target levels and indicators to monitor 
progress towards the target. Moreover, since the WHO Regional Director for Europe is to report 
progress towards achieving the targets as European averages, the regional targets need to be 
informed by monitoring of indicators at the country level.  
The Regional Office held a special meeting of an expert group to identify indicators in June 2012 
(56). The group agreed on the principle criteria for selecting indicators for five of the six areas 
(excluding well-being), indicators should: 
• be routinely collected, simple and inexpensive to administer for Member States where 
possible (most often already being processed for international databases);  
• have a high level of robustness and validity, to measure target achievement;  
• inform policy options, to support decisions on priorities;  
• offer disaggregation at the lowest regional or subnational level possible to facilitate 
monitoring of regional differences within and across Member States;  
• be able to be stratified by age and sex, and where possible by ethnicity, socioeconomic 
characteristics and vulnerable groups; and 
• be available in the majority of Member States.  
For these purposes, health information routinely collected by countries should be used as much as 
possible, and new data collection should be avoided where possible.  
Methods for setting target levels 
The technical methods used for setting a target level and selecting existing or developing new 
indicators vary according the objectives to be attained. Several approaches exist that vary in relation 
to the data and evidence required and the complexity of calculation methods (see Box 15 on setting 
target levels and identifying indicators for NCDs). The following sections outline alternative 
methods for the first target area: the burden of disease and risk factors.  
Counterfactual method 
This method is based on comparing a biologically achievable or theoretical minimum with the 
existing reality according to available information. Murray and Lopez (57) described it in 1999 as 
taxonomy of counterfactual exposure distributions that assist with mapping options for policy 
implementation. These include distributions that correspond to a theoretical minimum, a plausible 
minimum, a feasible minimum and a cost-effective minimum of any risk factor or target described. 
For this target area the method takes account of the fact that a certain burden of disease will be 
unavoidable, no matter how favourable the environment.  
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Trend analysis 
This method is often used, and involves observing and documenting trends by geographical areas, 
either within or across countries or grouping of countries, or by social, economic or demographic 
population characteristics, such as sex, educational level or occupational group. It provides a basis 
for considering the evolution of broader determinants of health, risk factors, and health outcomes or 
consequences, between different groups. A target could therefore be set to reduce differences in 
rates between groups of countries.  
Other methods 
Many other methods exist, including approaches to further refining target setting. One is the pooling 
of intervention studies: studies examining and quantifying the effect of interventions (including 
cost–effectiveness) from various countries in Europe can be pooled and the percentage reduction of 
the outcome of the intervention can be used as a quantifier for the target. These are important as 
they link directly with policy options.  
Comparative risk assessments offer another approach: these studies examine and quantify the effect 
of risk factors on disease, and predict the development of the disease burden based on predictions 
with changes in the determinants over time. There is plenty of literature on this subject, especially 
from Europe.  
Box 15. Illustrating approaches to setting target levels and identifying 
indicators for NCDs  
The counterfactual method 
An indicator of premature mortality from diseases of the circulatory system, a target area for NCDs, could be 
used. (Premature mortality is used purely for illustrative purposes and may not be appropriate, since it 
excludes the elderly as an important vulnerable group.) The target content can be formulated in different 
ways, including: 
• a reduction of mortality from diseases of the circulatory system in the European Region of at least 1. 5% by 
2020, with the most significant reductions achieved in countries with the highest current rates; or  
• a reduction of mortality from diseases of the circulatory system in the Region to the lowest current 
subregional average. This would immediately become a quantified target, as it would set the European 
Region average to decline from 100 per 100 000 in 2010 to a currently observed rate within the 
Region by in 2020.  
The indicator for this target could be “age-standardized mortality rate for diseases of the circulatory system 
per 100 000 population, 0–64 years”. The figure below shows this rate for all countries in the European 
Region, as well as the average rates for the previously used subgroups of countries within the European 
Region: 
 the 15 countries belonging to the EU before 1 May 2004 (EU15);  
 the 12 countries  joining the EU since May 2004 (EU12); and 
 the Commonwealth of Independent States (CIS) until 2006 (see Annex 1 for details). 
To achieve an age-standardized mortality rate of zero would be a theoretical but not physiologically plausible 
minimum rate. One could argue, however, that, given the right environment and conditions, all countries in 
Europe should be able to attain the lowest rate (in this example, that of Israel) as it is already a biological 
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reality, and hence plausible; or, as noted above, to reach the lowest current subregional average (in this 
example, that of the EU15) as this is also already observed, and hence feasible.  
Alternatively, one could argue that countries with the highest rates should be able to attain the average rate 
for the whole Region. Further information from intervention studies would be required to debate a cost-
effective minimum. The choice of the standard (often called the counterfactual) against which progress 
would be compared and the target set would either be through expert opinion, consensus or other methods 
(described further below).  
The highest country rate in this figure is more than 10 times the lowest, and more than 2.5 times the average 
for the European Region. Depending on which rate is used as the counterfactual or target rate, the percentage 
reduction of the target would vary. Alternatively, a positive expression could be used, focusing on life 
expectancy rather than mortality; the highest life expectancy in the Region could then be identified as 
counterfactual for regional comparisons.  
To quantify this sensibly, further steps would be required. Moreover, many factors determine the differences 
in rates, but overall mortality is an important one, where low rates of cause-specific mortality may only 
reflect high rates of competing mortality from other avoidable causes.  
Trend analyses 
Another illustration of mortality from diseases of the circulatory system demonstrates how trends in rates can 
be used to arrive at a target, this time in the area of inequalities. The figure below shows how premature 
mortality from diseases of the circulatory system has changed in Europe. It demonstrates that the differences 
in rates between countries in the Region have increased, particularly in the past 20 years. This may lead to 
the formulation of a target such as “a reduction in the inequalities in mortality from diseases of the 
circulatory system within the European Region by x%”. The indicator would be the “proportional difference 
in mortality from diseases of the circulatory system between the highest and the lowest countries”. 
Alternatively, the target could be to “reduce the differential of mortality from diseases of the circulatory 
system between certain subgroups of countries (that would need to be identified) by x%”; many different 
options are available. In both cases, the percentage of reduction needs to be set with the agreement of 
Member States.  
Further analysis is required to assess whether a quantified target is realistic. This would include the 
examination of correlations using predictor variables, particularly those that are prone to respond to 
interventions, or the analysis of quintiles where the countries within the best quintile are examined for 
commonalities. This requires more detailed knowledge of the effectiveness of interventions to reduce either 
disease or risk factors/determinants. This analysis would examine the commonalities of countries, subgroups 
or regions with the highest and the lowest rates.  
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Premature mortality from diseases of the circulatory system in countries and subregions in the European Region, last reported data 2006–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6).  
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Trends in premature mortality from diseases of the circulatory system in countries and subregions in the European Region, 1980–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6).  
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Pooling of intervention studies 
As a hypothetical example, if the aggressive use of statins and certain health system improvements have 
reduced mortality from diseases of the circulatory system by 5% in some countries, then a potential target 
could be set at a 5% reduction in premature mortality rates for diseases of the circulatory system.  
Comparative risk assessments 
Here is another hypothetical example. If declines in tobacco consumption have been followed by a reduction 
in mortality from diseases of the circulatory system by 10% in some countries, then a potential target could 
be set at a 10% reduction in premature mortality rates for diseases of the circulatory system.  
Setting target levels and selecting indicators to monitor progress 
towards 2020 
The expert group meeting in June 2012 proposed a preliminary set of potential indicators for 
monitoring the six overarching targets (56). The main points of agreement from this meeting should 
be noted in the light of the indicators currently available in the Health for All database and a few 
other sources.  
• There should be a set of core indicators for which data should be available across the 
European Region, with the opportunity for countries to expand this list and make use of 
additional indicators available to them.  
• Member States should report on core indicators and refer to the expanded list if resources are 
available.  
• A dimension of accountability is needed: the list of core indicators could provide it.  
As Member States agreed that the baseline for monitoring of Health 2020 targets should be set at 
2010, this provides a ten-year window for monitoring and reporting progress.  
Based on criteria proposed to monitor progress, the expert group proposed a target level for each of 
the overarching target areas, and drafted two sets of indicators for further discussion (see Table 2): 
core indicators that clearly meet all or almost all criteria and additional indicators compiled in a 
menu from which Member States may select the most relevant or to which they may wish to make 
additions where appropriate.  
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Table 2. Monitoring progress towards Health 2020 
Health 2020 
overarching 
target 
Key target areas  Proposed core indicators Additional potential indicators
1. Reduce 
premature 
mortality in 
Europe by 
2020 
1.1. 1.5% relative annual reduction in 
overall mortality from diseases of the 
circulatory system, neoplasms, 
diabetes, and chronic respiratory 
disease by 2020 
1.2. Achieve and sustain elimination 
of selected vaccine preventable 
diseases (poliomyelitis, measles, 
rubella, prevention of congenital 
rubella syndrome) 
1.3. 30% reduction in road traffic 
injuries by 2020 
1.1a. Age-standardized all-cause mortality rate per 
100 000 population, disaggregated by sex and 
broad cause of death 
1.1b. Prevalence of major risk factors, including 
those formulated in the global NCD monitoring 
framework 
1.1c. Infant mortality per 1 000 live births 
1.2a. % of children vaccinated against measles, 
poliomyelitis and rubella 
1.3a. Age-standardized mortality rates per 
100 000 population from all external causes 
a. Overall and premature mortality for four 
major NCDs by sex (diseases of the circulatory 
system, neoplasms, diabetes, and chronic 
respiratory disease) 
b. Daily tobacco smoking in population aged 
15 years and over by 2020 
c. Alcohol consumption 
d. Overweight/obesity 
e. Transport accidents 
f. Accidental poisonings 
g. Alcohol poisoning 
h. Suicides 
i. Accidental falls 
j. Homicides and assaults 
2. Increase life 
expectancy in 
Europe 
2.1. Continued increase in life 
expectancy at current rate coupled 
with either 50% or 2530% 
reduction in the difference in life 
expectancy between European 
populations by 2020 
2.1a. Life expectancy at birth a. Life expectancy at birth and at ages 1, 15, 45 
and 65 
b. Healthy life expectancy at birth and 65 
3. Reduce 
inequities in 
health in 
Europe (social 
determinants 
target) 
3.1. Reduce the gap in health status 
between population groups 
experiencing social exclusion and 
poverty and the rest of the population 
 
3.1a. % of early school leavers 
3.1b. Poverty, including in special groups 
(children, the elderly) 
3.1c. Infant mortality per1 000 live births 
3.1d. Qualitative indicator documenting 
establishment of national policy addressing health 
inequities 
3.1e. Life expectancy 
a. % of primary school enrolment 
b. % of children at risk of poverty 
c. Life expectancy by sex and rural/urban split 
d. Human Development Index – adjusted for 
inequities 
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3.1f. GINI coefficient 
3.1g. Human Development Index 
3.1h. Suicide/homicide rates 
3.1i. Teenage pregnancy rates 
4. Enhance the 
well-being of 
the European 
population 
To be developed during 2013 4.1a. Prevalence of childhood obesity 
4.1b. To be developed (including mental health, ill 
health, mortality, including suicide rates; 
objective and subjective measures) 
a. Participation rates of people with mental 
disorders in employment 
5. Provide 
universal 
coverage and 
the “right to 
health” in 
Europe 
5.1. Funding systems for health care 
to guarantee universal coverage, 
solidarity and sustainability by 2020 
5.1a. Private households’ OOP expenditure as a 
proportion of total health expenditure 
5.1b. % of children vaccinated against measles, 
poliomyelitis and rubella 
5.1c. % of low-birth-weight babies (<2. 5 kg) 
5.1d. Per capita expenditure on health (as % of 
GDP) 
a. More detail on OOP expenditure indicator 
6. Establish 
national 
targets set by 
Member 
States 
6.1 National target-setting processes 
established and targets formulated 
6.1a. Qualitative indicator documenting both 
process and formulation 
6.1b. Qualitative indicator documenting use of 
health-in-all-policies approach 
6.1c. Qualitative indicator documenting: (i) 
establishment of national Health 2020 policy; (ii) 
implementation plan; (iii) accountability 
mechanism 
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The indicators proposed by the expert group are placeholders. Following the 2012 session of the 
Regional Committee, the WHO Regional Office for Europe started extensive consultation with 
Member States to finalize the indicators for the agreed targets for submission to the Regional 
Committee in 2013. This includes discussions at all governing body meetings and a written, web-
based consultation. 
To stimulate the debate on relevant indicators for the endorsed overarching targets for Health 2020, 
some of the indicators proposed by the expert group are used here to illustrate a baseline, including 
trends for four of the overarching targets. In addition, a framework for monitoring is illustrated for 
one indicator.  
Target 1. Reduce premature mortality in Europe by 2020 
The key target areas involve the relative reduction in overall mortality from diseases of the 
circulatory system, neoplasms, diabetes and chronic respiratory disease; elimination of selected 
vaccine preventable diseases and reducing road traffic accidents.  
Indicator: age-standardized all-cause mortality rate per 100 000 population, 
disaggregated by sex and broad cause of death 
As noted in Chapter 1, although the overall average has decreased in recent years, all-cause 
mortality rates show large discrepancies across the European Region (see Fig. 10, p. 20).  
Premature mortality (deaths occurring before the age of 65 years), disaggregated by broad groups of 
causes of death and sex, has been suggested as a potential additional indicator for this target (Fig. 
64). Trends for the European Region show large differences of magnitude between males and 
females, twofold or higher for all groups of causes, but particularly marked for diseases of the 
circulatory system, neoplasms and external causes. Disease incidence patterns also diverge: females 
are now similarly affected by both diseases of the circulatory system and neoplasms and affected to 
a lesser extent by external causes. Males are significantly more affected by diseases of the 
circulatory system than any other cause group, followed by external causes and neoplasms. 
Mortality trends for most groups of causes are decreasing, although at different paces, except for 
diseases of the digestive system (most related to chronic liver disease and cirrhosis).  
Indicator: prevalence of major risk factors 
Another proposed core indicator is the prevalence of major risk factors for NCDs, including tobacco 
smoking and alcohol consumption. The prevalence of regular smoking has decreased towards 25% 
in Europe. Nevertheless, smoking prevalence rates are not recorded in all countries, which poses 
some challenges to monitoring.  
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Fig. 64. Trends in premature mortality by sex and main broad group of causes of death in the 
European Region, 1990–2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6).  
In contrast, alcohol consumption rates in some parts of the Region have risen strikingly fast, 
masked by the overall European Regional average (Fig. 65). This is accompanied by similar 
patterns of mortality from alcohol-related causes.  
Indicator: percentage of children vaccinated against measles, poliomyelitis and rubella 
A crucial target area for reducing premature mortality is achieving and sustaining the elimination of 
selected vaccine-preventable diseases. Potential indicators for monitoring are those relating to 
efforts of the health system, particularly immunization. Over the past decade, the proportion of 
children protected against measles and poliomyelitis has reached levels above 90% in the European 
Region (Fig. 66). The levels have been slightly higher in countries in eastern Europe and central 
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Asia. In some countries, recent declines in immunization rates have created the conditions for 
outbreaks. Increased efforts will be required to achieve effective protection of the population in 
such scenarios.  
Fig. 65. Average alcohol consumption per capita among the population aged 15 years and over in 
the European Region, last reported data, 1980–2007 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6).  
Fig. 66. Immunization against measles and poliomyelitis in the European Region, 1980–2010 
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Source: European Health for All database (6).  
Indicator: age-standardized mortality rates per 100 000 population from all external 
causes 
Given their importance for mortality, road traffic accidents (and other external causes of death) are 
considered another relevant target area. In 2010, mortality rates from external causes varied from 25 
to 103 per 100 000 in the Region, a nearly fourfold difference (see Fig. 36, p. 51). Rates from 
specific external causes also vary considerably between countries (Fig. 67), as discussed in Chapter 
1.  
Fig. 67. Mortality from external causes of death in the European Region, 1980–2010 
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Sources: European Health for All and mortality databases (6, 11).  
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Target 2. Increase life expectancy in Europe 
The key target area is the continued increase in life expectancy at the current rate, combined with a 
reduction in gaps between populations.  
Indicator: life expectancy at birth 
Over the past three decades, life expectancy has increased in Europe at an average annual pace of 
0.17 years (see Fig. 4, p. 13). Projections suggest that it will nearly reach 81 years by 2050, at a 
pace similar to that in 1980–2010 (7). Nevertheless, there are important gaps between groups of 
countries. For example, in 2010 life expectancy in some western European countries had already 
reached the level expected for the whole Region in 2050, and will reach 85 years in 2050. In 
contrast, others are expected to reach only 75 years of life expectancy by 2050 – the level observed 
in the European Region as a whole in 2010 – or that already achieved by some countries in 1985.  
Target 3. Reduce inequities in health in Europe (social determinants target) 
The target area will address reductions in health gradients and gaps between population subgroups 
in countries. The focus is likely to be on those experiencing social exclusion and poverty, in 
comparison to the rest of the population. This will include differences in life expectancy between 
European populations by 2020.  
Target 4. Enhance the well-being of the European population 
This target area requires considerable new work. The WHO Regional Office for Europe has 
launched an initiative on measuring and setting targets for well-being, led by international experts. 
This group’s proposals for indicators will be intensively discussed with Member States, as 
discussed in Chapter 3. The group has suggested that the prevalence of childhood obesity may be 
one of several indicators in this area.  
Indicator: prevalence of childhood obesity 
New data on the prevalence of obesity are only slowly becoming available for European countries, 
and some proxy measures linked to health behaviours may be used as alternatives. The latest survey 
of schoolchildren for the HBSC study provides information on their health behaviours, including 
physical activity and nutritional habits (40). While 15% of 15-year-olds reported moderate-to-
vigorous physical activity in their daily routine (Fig. 68), boys were twice as likely to do so as girls 
(19% versus 10%). The highest reported rate for both boys and girls was nearly three times the 
lowest. In relation to healthy eating behaviours, 31% of adolescents overall reported eating fruit 
daily, although the rates were higher for girls than boys (35% and 27%, respectively). Variation 
between countries was considerable, with up to twofold differences between boys and girls.  
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Fig. 68. Prevalence of moderate-to-vigorous physical activity and fruit consumption among 15-year-olds in countries in the European Region, by sex, 
2009/2010 
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Source: Currie et al. (40).  
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Target 5. Provide universal coverage and the “right to health” in Europe 
The key target areas involve the funding of health systems to guarantee universal coverage, which 
requires solidarity and sustainability in order to be achieved by 2020.  
Indicator: private households’ OOP expenditure as a proportion of total health 
expenditure 
This indicator provides information on health expenditures made by households that are not covered 
by a pooled fund (whether from general taxes or insurance schemes), and is a core indicator for 
universal coverage (representing one of its three dimensions). The average share of OOP 
expenditure in total health expenditure in the European Region was 23% in 2009 (Fig. 69), but 
ranged from a low of 5.7% to a high of 79.5% (a fourteenfold gap between countries), as discussed 
in Chapter 1.  
Fig. 69. OOP expenditure as a proportion of total health expenditure in the European Region, 
1995–2009 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: European Health for All database (6).  
Target 6. Establish national targets set by Member States 
This target area will reflect the processes put in place or strengthened by Member States across the 
European Region (see the example in Box 14), further described below. The focus is likely to be on 
updating existing efforts, and on adding new areas relevant to the Health 2020 policy and to 
countries that strengthen the monitoring and reporting of targets and indicators at the country level. 
In addition, the WHO Regional Office for Europe will support an exchange of best practices across 
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Monitoring of targets and indicators for Health 2020 
The Regional Office is finalizing a framework for the monitoring of targets and indicators for 
Health 2020, in consultation with Member States. Feedback from the 2012 session of the Regional 
Committee indicated that the following mechanisms would be appreciated.  
Reporting mechanisms for Member States 
Existing reporting mechanisms should be used to the greatest possible extent. This includes annual 
or biannual reporting to the Health for All or other databases hosted by the WHO Regional Office 
for Europe, including joint data collection with EUROSTAT and OECD. The Regional Office will 
be required to monitor and harvest the information from the databases and ensure its appropriate 
synthesis, analysis and presentation to Member States.  
Platform(s) for reporting from Member States 
Member States should not have to provide additional information except where non-routine data are 
required (potentially for targets 4 and 6). Where indicators are not routinely collected (through 
either the national reporting system or regular surveys) and already reported to WHO, estimates 
from WHO headquarters or joint United Nations efforts that are accepted by Member States could 
be used. The WHO Regional Office for Europe will hold discussions with Member States to 
determine what options may be pursued to achieve this, and continually consult the SCRC.  
Existing platforms, particularly the annual data collection for the Health for All database (6), should 
be used until the Division of Information, Evidence, Research and Innovation has established a 
single platform merging all the Regional Office’s databases. This is envisaged for early 2013. Joint 
data collection with EUROSTAT and OECD feeds into these mechanisms, so additional reporting 
will not be required.  
Over the coming years, however, this platform is to be replaced by the integrated European health 
information system that the Regional Office is establishing in collaboration with the European 
Commission and OECD. The Regional Office’s vision is to launch this system with the core 
indicators required for Health 2020 monitoring and reporting, as all Member States would accept 
this. The Regional Office will discuss this important issue further with the European Commission 
and OECD, to agree on a common way forward. In due course, the scope of the system may be 
expanded, reflecting opportunities, options and eventual agreements. For instance, the Regional 
Office is analysing how existing platforms can be transferred to an electronic infrastructure for a 
new system and will report on this regularly to Member States.  
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For indicators on which information is not routinely collected at present (such as national target-
setting efforts and those addressing well-being), existing mechanisms can support any new effort. 
The Regional Office therefore proposes the following.  
• The Regional Office’s technical programmes may collect information on the qualitative 
indicators from Member States through minimal questionnaires, largely requiring a yes/no 
response; a narrative can be provided, if desired. Regional Office staff should canvass their 
technical counterparts in countries on this.  
• The well-being indicators being developed in 2013 will include a mix of routinely reported 
data and self-reported information, and will require additional reporting. The Regional 
Office will regularly consult WHO Member States and governing bodies on the approach to 
data collection in this area. Existing mechanisms (for example, surveys by Gallup 
International or other groups conducting annual surveys in all European countries) should be 
explored for this purpose. The Regional Office is investigating these options (which should 
not pose any additional burden, including a financial one, on countries) with such providers 
and will ensure consultation, for example, through the existing annual efforts related to the 
Health for All database.  
Synthesis of reporting through European health statistics and the 
Regional Director’s report 
The WHO Regional Office for Europe proposes to provide a synthesis of all data received through 
existing mechanisms every two years through a special section in a new publication, provisionally 
called “European health statistics”. Prior to publication, the Regional Office will conduct extensive 
written consultation with Member States. Reporting may take the form of detailed analyses of the 
data and their presentation in tables and graphs as regional averages, potentially new subregional 
averages, ranges giving maximum and minimum values, or detailed interpretative text and 
executive summaries.  
To complement this biennial reporting, the WHO Regional Director for Europe will include an 
abridged report on the Health 2020 indicators in her annual report to the Regional Committee. This 
will provide a further platform for direct consultation and feedback. Analysis as outlined above is 
proposed. In addition, every 2–3 years the Regional Director will give an update on progress 
towards the quantified targets for the European Region. The SCRC meeting held in May of each 
year could function as a further platform for consultation on the results, in preparation for the 
Regional Director’s report to the Regional Committee.  
Major milestone reporting on the Health 2020 targets and indicators is envisaged to be included in 
the European health report, which the Regional Office publishes every three years. This will also 
permit more detailed analysis and discussion. The first milestone report would thus be in 2015, 
followed by 2018 and a final report in 2020. Moreover, the Regional Office is revitalizing its 
Highlights on Health series of country profiles; this medium can make progress immediately 
visible. The Regional Office is also bringing back a brief annual publication on core indicators for 
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all European countries, with varying themes every year. It will publish the information in all these 
reports using media including the Regional Office web site.  
Accountability 
The Regional Office Secretariat is working out a process to outline the actions to be taken when: 
• Member States do not regularly report on all indicators; or 
• the targets as proposed do not appear to be on track for achievement.  
In addition, it will need to share and highlight how countries across the Region use information at 
the national level – perhaps in comparison to the regional level and other countries in the Region – 
to inform health policies and programmes, and to provide insight into effective approaches in 
different contexts. Clearly, the wide range of activities underway can illustrate concretely that every 
country gains further insights through better national and regional health information: for example, 
through national and international comparative benchmarking studies that are linked to support 
national health policy, as is the case in the Netherlands (Box 16).  
Box 16. Case study: benchmarking health in the Netherlands with the European 
Community Health Indicators 
Reflecting a 2006 ambition to move the Netherlands back into the top five healthiest European countries, the 
country adopted a new health policy approach to prevention. To provide evidence, the Ministry of Health, 
Welfare and Sport commissioned the National Institute for Public Health and the Environment (RIVM) to 
update the picture of public health and benchmark the Netherlands in the light of other EU Member States. In 
2008 RIVM published the report, entitled Dare to compare (58), which responded to the following 
questions.  
• How does Dutch public health compare with public health in other European countries in general, and with 
a focus on young people and the elderly? Where possible, issues of socio economic inequalities will be 
addressed.  
• To what extent are Dutch data available and suitable to meet the specifications of the European Community 
Health Indicators shortlist, and what are the main gaps and bottlenecks when making international 
comparisons based on the shortlist? 
A close examination of the shortlist of European Community Health Indicators covering public health 
showed that the Netherlands ranges among the top five healthiest European countries for some issues, but 
among the bottom countries for others. This diversity underlined the need for further investigation of causal 
pathways and patterns. The director of RIVM raised essential questions, such as why the country was doing 
so well on some issues and what could be learned for policy action on the ones that lag behind.  
Importantly, the report is primarily aimed at policy-makers and public health professionals in the 
Netherlands, and provides a direct comparison between the Netherlands and other EU Member States on 
many current issues. Topics include health status, the determinants of health, prevention and care, and the 
demographic and socioeconomic situation. The report also gives special attention to health at different stages 
of life, covering children, young people and elderly people.  
The monitoring framework 
The WHO Regional Office for Europe will populate a detailed framework with all indicators, as 
outlined in Table 3, and present it to Member States for discussion and decisions. This framework 
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outlines the data collection mechanisms, consultation events, reporting formats and timelines for all 
targets and indicators.  
Chapter 2 has documented the process of establishing the overarching targets of the Health 2020 
policy – what we are aiming for as a Region – and proposes an approach to setting achievable 
targets and indicators to monitor progress at the regional level. A key area for further development 
is measuring progress on health in the context of well-being, or what we value: this is the subject of 
Chapter 3. 
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Table 3. Excerpt from an eventual detailed framework for all indicators 
Overarching 
target 
Key target 
areas 
Potential 
quantification 
Additional 
potential 
indicators 
Number of 
countries 
reporting 
Data 
collection 
mechanism 
Consultation 
with Member 
States 
Reporting 
Format Timeline  
1. Reduce 
premature 
mortality in 
Europe by 
2020 
1.1. 1.5% 
relative annual 
reduction in 
overall mortality 
from diseases of 
the circulatory 
system, 
neoplasms, 
diabetes, and 
chronic 
respiratory 
disease by 2020 
(To be aligned with 
global NCD target-
setting efforts) 
1a. Age-
standardized all-
cause mortality 
per 100 000 
population (as 
first indicator), 
disaggregated 
by sex and 
broad cause of 
death 
a. Overall and 
premature 
mortality for 
four major 
NCDs by sex 
(diseases of the 
circulatory 
system, 
neoplasms, 
diabetes, and 
chronic 
respiratory 
disease) 
43 Health for All 
database 
through 
existing annual 
mechanism 
(WHO 
prompt) 
In Health for All 
context 
 
May SCRC 
 
Additional 
written 
consultation 
 
Information 
document at RC 
Direct to countries 
(existing) 
 
Regional Director’s 
report to the 
Regional 
Committee 
 
European health 
statistics 
 
European health 
report 
2013 
 
 
2014 
 
 
 
 
2015 
 3. How we are getting there and what we value: the case  
for measuring well-being 
As mentioned, WHO defines heath as “not merely the absence of disease or infirmity” but 
“physical, mental and social well-being” (5). Nevertheless, for more than 60 years WHO has neither 
measured nor reported on well-being, focusing instead on death, disease and disability. While this 
monitoring function is clearly part of the Organization’s core mandate, WHO needs to partner other 
institutions to describe populations’ well-being in Europe and measure progress in enhancing it in 
the context of Health 2020. As described in Chapter 2, the Region has reached consensus on the 
long-range goal of improving the health and well-being of European populations by 2020. 
Moreover, well-being provides an important mechanism for creating an integrated vision of health, 
with an opportunity to link to governance and ensure that health remains on all policy agendas.  
The WHO Regional Office for Europe convened an expert group in February and June 2012 to 
review, discuss and advise on the different definitions and frameworks for well-being (59,60), on 
which there have been many complementary efforts and recent contributions. This chapter provides 
a roadmap for developing a European target and indicators on well-being and health, and lays out a 
process for advancing conceptual clarity and increasing the usefulness of information on health and 
well-being for policy-makers. It aims to answer the following questions.  
• What do we mean by well-being?  
• Why is it important for health? 
• Why are governments and societies across Europe interested in health and well-being? 
• How can we measure levels of well-being?  
• What can we build on? 
• What are the challenges in measuring health and well-being? 
• Where are we now? 
• How can this information be used to improve health and well-being? 
What do we mean by well-being? 
What makes up a good life is one of the basic moral discussions in all philosophical traditions. 
Across countries, people usually agree on the big picture, or minimum ingredients of well-being. 
What matters to people’s lives is also surprisingly constant, indicating that what we value does not 
change easily, even though the identification of important areas or components remains a normative 
exercise, drawing on different notions of the basic nature of well-being (its ontology) and on how 
knowledge can be gained about it (its epistemology). The first issue in defining well-being is to 
clarify these different concepts and their underlying assumptions.  
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Elements of objective well-being include people’s living conditions and their opportunities to 
realize their potential: opportunities that in principle should be equitably distributed among all 
people, without discrimination on any basis. A fair chance at health is one part of objective well-
being. Elements of subjective well-being include people’s experiences of their own lives. Based on 
these elements, well-being has either been framed as a composite of different building blocks or a 
concept in itself.  
The Commission on the Measurement of Economic Performance and Social Progress’ 
recommendations on assessing functioning and capabilities (61) illustrate the composite approach: 
this typically draws on an objective epistemology, using objective measurement tools and 
indicators, such as income, education or mortality rates. This approach sees health as a component 
of the composite of well-being. A large body of literature and research (61–63) defines well-being 
as a function of life opportunities and achievements. It is multidimensional, reflecting people’s 
functioning or the “flourishing of selected human normal functions” (64) – such as consumption 
and personal security – and their capabilities – the objective conditions in which choices are made 
and that shape people’s abilities to transform resources into given ends, such as health.  
For the conceptual approach, the ontological method is typically linked to a subjective 
epistemology, with knowledge about well-being gained through people reporting their own 
perceptions. This combination of ontology and epistemology is often called subjective well-being: 
what someone feels is what matters. Although there is significant debate on the content and 
usefulness of subjective elements of well-being, including what people feel and report (as opposed 
to objective elements only) clearly adds different information for policy discussions. Nevertheless, 
in policy implementation and evaluation, governments are more easily held accountable for 
objective conditions.  
What people feel and experience can be described in different ways. A new OECD review (65) 
documented three separate areas, each contributing important information, that make up subjective 
well-being: 
• eudemonic well-being – self perceptions of autonomy, competence, purpose of life, locus of 
control;  
• positive and negative state – experience of joy, happiness, anxiety, sadness;  
• life evaluation – a reflective assessment.  
Other conceptual models have different underlying assumptions. Moreover, well-being is envisaged 
as both a state and a dynamic process: a definition and a route that could illustrate pathways. 
Frameworks sometimes mix these aspects.  
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influences future health through a range of mechanisms such as the functioning of the immune 
system and responses to stress (68). Reviews of studies to date suggest that well-being has a 
substantial (though variable) effect on health that is comparable to that of other factors, such as a 
healthy diet, that have more often been the targets of public health interventions (69).  
Moreover, the literature documents two-way relationships between different areas of well-being: it 
is clear that health influences overall well-being, but well-being predicts future health or illness. 
Well-being and health are interactive concepts with some common determinants, such as the health 
system. Other determinants include the broader political, economic and social context, as well as 
other intermediary factors, such as the degree of social stratification or exposures that could either 
increase or reduce vulnerabilities. Fig. 71 shows another way to start to conceptualize these 
relationships, also connecting the role of the health system.  
Fig. 71. Health and well-being: an overview of determinants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Measurement of and target setting for well-being (59).  
Discussions with representatives from European Member States and technical experts during the 
consultation on Health 2020 provided qualitative evidence that people across the European Region 
value health and want to minimize disease: they value social cohesion and inclusion as important 
broader determinants of health and well-being, giving all people a fair chance of health. People also 
value security and safety, which are related to health in the context of well-being. Common values 
across Europe increase the likelihood of having a regional target on health and well-being.  
Of course, other domains of well-being are valued or matter. Nevertheless, full agreement on or a 
static understanding of what well-being means is needed to develop ways to improve well-being 
and eventually to measure and monitor it.  
Determinants Economic/environment
Health system
Wellbeing
Health
- structural
- intermediate
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Box 17. Key messages – the meaning of well-being, its importance to health 
and its stability across populations 
• One approach to well-being concerns the meeting of people’s objective basic needs and the enabling of 
their capabilities; another approach considers people’s subjective perceptions.  
• Health can be conceptualized as part of well-being, as both a determinant and an outcome.  
• Common values across Europe increase the likelihood of having a regional target on health and well-being.  
Why are governments and societies across Europe interested in 
health and well-being? 
Improving or at least maintaining well-being is part of the social contract between governments and 
the people they represent. No particular sector or service is responsible for ensuring a good life; it is 
a multidimensional concept with multiple determinants. Improving population well-being can be a 
platform on which to develop a common agenda, including a whole-of-government approach across 
sectors and stakeholders. Health ministers and ministries all know that well-being is part of the 
WHO definition of health. As noted, some of the determinants of well-being are also determinants 
of health.  
In addition to governments, major actors interested in well-being include civil-society groups, 
patient groups, wellness and health promotion practitioners, and media organizations. Various 
groups – government and nongovernmental, public and private – try to influence the policy-making 
process and/or programmes in one or more sectors to improve well-being outcomes for people and 
society as a whole. Over the last decade, the goal of enhancing population well-being in Iceland 
catalysed an effort to measure progress at the national level and to inform policies across 
government sectors (Box 18). The remaining sections of this chapter lay out a range of issues and 
challenges to address, along with approaches to do so over the next several years.  
Box 18. Case study: enhancing well-being in Iceland – 6 steps linking 
assessment and interventions to improve well-being 
1. Deciding to start measuring well-being 
Over the last decade, Iceland has focused increased attention on the goal of enhancing well-being. As a 
result, interest has grown in assessing well-being status and exploring whether any interventions might be 
successful in increasing it for both individuals and society as a whole.  
Inspired by studies looking at well-being from an epidemiological perspective (such as Huppert et al. (70)) 
and emphasizing the need for measuring positive mental health (Stewart-Brown (71)), public health 
authorities in Iceland became very interested in measuring well-being at the population level. They were 
keen to explore both well-being and the determinants of health, which research has revealed are not 
necessarily the same (Wilkinson & Marmot (72), Huppert (73)).  
2. Selecting methods and processes, including stakeholders, and gathering information 
When the Public Health Institute of Iceland (which was incorporated into the Directorate of Health in 2011) 
decided to implement a national survey on health and well-being in 2007, a module on well-being therefore 
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needed to be constructed. A group of experts was convened to decide what to include from measures already 
published:  
• a single measure of happiness;  
• the WHO-Five Well-being Index (WHO-5) (74);  
• Satisfaction With Life Scale (SWLS) created by Diener et al. (75);  
• a short version of the Perceived Stress Scale (PSS) created by Cohen et al. (76);  
• the short version of the Warwick-Edinburgh Mental Well-being Scale (WEMWBS) created by Stewart-
Brown et al. (77), which was translated specially for this purpose and has since been used as the main 
measure on well-being within public policy.  
All these measures were included in the health and well-being study in 2007, which was repeated in 2009 
and 2012. The second and third rounds added further scales, including the Meaning in Life Scale by Steger 
& Samman (78) and new well-being questions based on Huppert & So’s conceptual framework for defining 
well-being (79).  
3. Ensuring the assessment responds to the current context 
When its banking system collapsed in October 2008, Iceland’s public health authorities decided to conduct a 
new study to assess the impact of the economic crisis on Icelanders’ well-being. The protocol included the 
single measure of happiness, WEMWBS and PSS.  
4. Presenting and communicating the results 
An analysis of the impact of the economic crisis in Iceland, using data from studies on both health and well-
being and economics and well-being, documented the findings (Gudmundsdottir (80)). An open seminar 
presented the results, including a panel discussion with the Minister of Welfare and the studies’ project 
leader. The panel discussed the kind of society that would increase well-being in the population, and 
highlighted the following points.  
• Good social relationships – the quality of relationships with family and friends, along with the amount of 
time spent with family – predict happiness.  
• Difficulty making ends meet is the strongest predictor of unhappiness.  
• The population subgroups that find it difficult to make ends meet are not the same as the unemployed or 
those in the lowest income group.  
The results and the reaction from the Minister received extensive attention from the mass media 
(newspapers, radio and television).  
5. Ensuring an impact on policy-makers and policy 
The decision to measure well-being at the national level affected both health and whole-of-society policies. 
The well-being measures are used as an indicator in the Health 2020 policy for Iceland, as well as in a 
broader policy called Iceland 2020, led by the Prime Minister (81): a government policy on the economy and 
community. In addition, the Minister of Welfare was very interested in the results and gave good examples 
of how they could be incorporated in further policy-making efforts.  
6. Planning for the future 
As demonstrated, indicators of well-being are already used to monitor policies in Iceland, where several 
actions aim to increase well-being. It is therefore necessary to continue monitoring the population’s well-
being and further develop measures of mental well-being to increase its comprehensiveness.  
How can we measure levels of well-being? 
To improve and maintain people’s well-being, we need to describe in more detail what well-being 
comprises, and understand how to measure it. Researchers, organizations, governments and other 
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entities take a wide range of different approaches to describe both what areas or domains make up 
well-being and what should be measured for each. Some argue for objective measures, of air quality 
or level of hearing impairment, for example, whether measured by external scientific devices or by 
people responding to a questionnaire or an interview. Others include subjective measures: for 
example, people’s satisfaction with a particular area of their lives, such as their jobs or the quality 
of the environment. Some measures are quantitative; others include qualitative evaluations.  
Technical experts agree that multidimensional profiles of well-being are more likely to be used in 
policy-making, as they are easier to interpret. If an index is constructed of different elements or 
domains, each contributing part (level) and its value (weight) should be made transparent and be 
interpreted on its own, as well.  
Different methodologies and tools are used to collect information to measure each area. One of the 
most common tools is a survey, typically asking people to respond to specific questions. A very 
large number of standardized instruments has been developed to provide additional information on 
well-being associated with a particular type of morbidity, health condition or disability. These are 
often used in clinical trials as part of the outcomes assessed in the evaluation of new or different 
treatments. Standardized instruments, such as telephone or postal surveys, are also widely used 
across Europe to collect population-based information.  
To assist the process of developing a common concept and approach to measuring well-being at the 
population level across the European Region, the WHO Regional Office for Europe carried out a 
systematic literature review of validated tools to measure well-being. The search combined six key 
concepts: well-being, measurement tool, measurement properties, general population, observational 
studies, and peer-reviewed literature. It drew on databases covering biomedical, psychological and 
economics literature, resulting in some 3200 published articles for review, of which about 160 
contained information on indicators and measures. Box 19 highlights the main findings.  
Box 19. Key findings from WHO’s literature review of tools to measure well-
being 
• There are many definitions of health in the context of well-being: this requires more conceptual clarity.  
• Well-being is often treated as synonymous with quality of life and happiness.  
• Among various descriptions of tools used, the distinction between subjective and objective measures is 
often incorrect, or not distinguished from the measurement technique (for example, whether data are 
self-reported or externally assessed/measured).  
• The most common domains in all tools are economics, health, education, society/community and 
environment.  
• Within the different domains there is no consistency in the types of question asked or areas assessed.  
• A limited number of tools supports assessment at the population level: the vast majority focuses on specific 
clinical conditions.  
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In addition, the review showed that each instrument or tool uses different sets of domains, reflecting 
an implicit difference in how well-being is conceptualized and an explicit difference in how it is 
measured operationally.  
Two short questionnaires widely used to monitor well-being within and across populations are 
Cantril’s Ladder and the Personal Wellbeing Index (Table 4). Each provides measures of self-
reported health, self-perceived health and well-being.  
Table 4. Typical questions from Cantril’s Ladder and the Personal Wellbeing Index 
Question Scale used Source/User 
How satisfied are you with your 
life as a whole? 
Cantril’s Ladder, eleven-
point scale 
(worst possible = 0 to best 
possible = 10) 
OECD, Gallup 
Are you satisfied with: 
• your standard of living 
• your health 
• your achievements in life 
• your personal relationships 
• how safe you feel 
• feeling part of your community 
• your future security 
• your spirituality or religion? 
Personal Wellbeing Index, 
eleven-point Likert Scale 
(completely 
dissatisfied = 0 to 
completely satisfied = 10) 
International 
Wellbeing Group 
For subjective measures of well-being it is important to gauge whether the questions asked measure 
what they intend to measure. When there is no gold standard to use for comparison – such as 
people’s assessment of their personal relationships or the quality of their social networks – validity 
can be estimated in several other ways. Analysis can focus on the extent to which life circumstances 
and other candidate variables plausibly explain responses for an individual or the distribution of 
responses for a population. The extent to which they are correlated with other subjective and 
objective measures of well-being (correlation validity) can also be assessed: this is a measure of 
reliability. Another method is to consider how and whether the measures predict subsequent 
outcomes and behaviour (predictive validity).  
Methodological questions, as with any tools that use survey approaches, need to address whether 
the way data are collected, including the ordering and framing of questions, influences the response. 
It is also important to confirm whether the data collected can be compared over time for population 
health monitoring across or within countries. Another significant issue for monitoring is the role 
and potential influence of people’s expectations of a certain level of well-being. People consider 
their position in relation to an idealized norm, for example, within a community or a country, and 
this can influence their self-assessment. The importance of expectations can affect the analysis and 
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interpretation of the meaning and significance of different components of well-being and their 
distribution across different subpopulations.  
Another important aspect is knowing how to interpret the data collected, either for individuals or 
populations, including in what scale the data are expressed and what differences of 5%, 10% or 
20% mean. For measures of well-being that aim to capture the positive end of the distribution 
within a population, it is important to understand, for example, how health in the context of well-
being differs from being sick or being normal. For the latter, is there an expected set point or norm 
for well-being? 
In fact, the Australian Unity Wellbeing Index (82) surveys claim that the major strength of 
subjective well-being as an indicator is its reliability and stability, as shown by highly consistent 
results. Subjective well-being seems to behave like body temperature: it is normally constant. 
Strong challenges can make it fall or rise, but it normally returns to its set point. If it does not, this 
indicates overwhelming challenge and distress (Fig. 72). The Australian Unity Wellbeing Surveys 
identified some groups that are found below the normal range, such as people who are unemployed, 
live alone, have low incomes or provide informal care.  
Fig. 72. The relationship between stress and subjective well-being 
Subjective 
well-being
Stress
High
Low
Threshold
DISTRESSHomeostasis
No stress High stress
75
Level of environmental challenge
Dominant source of control
 
Source: Professor R. Cummins, Deakin University, Melbourne, Australia (unpublished).  
What can we build on? 
To monitor and report on health and well-being across the European Region, previous efforts to 
measure well-being at the population level are more relevant in practice than those focusing on 
specific clinical subpopulations. This report briefly examines five examples, led by a national 
government, another international organization, a private firm, WHO at the international level and 
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the United Nations. All feature health as an important component of well-being, or a factor directly 
affecting it; a few draw on the same data sets collected through international surveys, and some use 
different words – such as quality of life and happiness – to discuss what makes up a good life, or 
different ways to measure subjective well-being and self-reported objective well-being.  
Work in the United Kingdom 
A Member State with a long history of commitment to target setting and health measurement at the 
population and local levels is the United Kingdom. A programme to develop an accepted set of 
national statistics for understanding and monitoring national well-being, launched in 2010 and led 
by the Office for National Statistics (ONS), aims to put measures in place by around 2014. The 
initiative includes public debate (in which health is one of the major issues identified), a review of 
international work and further development of subjective well-being.  
The programme initially proposed domains in 2011, and ONS published a second iteration of a 
framework for the domains and proposed headline indicators in July 2012 (83). The current 
framework comprises 10 domains (Fig. 73).  
Fig. 73. Proposed well-being framework 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: United Kingdom Office for National Statistics licensed under the Open Government Licence v. 1. 0.  
Health is one of the proposed domains, including four headline indicators (84) as set out in Table 5. 
The ONS approach to measuring health within the context of well-being includes indictors of 
objective (including self-reported functioning or disability) and subjective (satisfaction measures – 
all self-reported) well-being.  
Proposed well-being framework  
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Table 5. Proposed headline measures for the health domain 
Objective Subjective 
• Healthy life expectancy (at birth) • Satisfaction with your health 
(percentage somewhat, mostly or 
completely satisfied with their health) 
• People not reporting a long-term 
limiting illness or disability  
 
• General Health Questionnaire (GHQ-
12) assessment (percentage with 
some evidence indicating probable 
psychological disturbance or mental 
ill health (85)) 
 
Source: United Kingdom Office for National Statistics licensed under the Open Government Licence v. 1. 0.  
ONS published background details on the domains in July 2012, along with the first set of 
experimental statistics on subjective well-being from its Annual Population Survey (86). These 
studies explore the headline measures in more detail and put them in the context of other measures 
of health and well-being – for example, looking at self-reported health and subjective well-being in 
relation to life expectancy, mortality, disease and physical health, mental health and lifestyles – 
each of which affects health. This supports the overall interpretation, and several key findings 
emerged.  
• People who feel that they are in good health are much more likely to report higher levels of 
subjective well-being; conversely, those who report poor health are much more likely to 
report lower subjective well-being.  
• Nevertheless, everyone who reported that their health was good or very good did not report 
relatively high levels of life satisfaction. Neither did all those who reported bad or very bad 
health also report low satisfaction with life. Similar patterns emerge in relation to the other 
aspects of subjective well-being.  
• The findings of the Annual Population Survey, combined with evidence from other sources, 
show that people’s well-being depends on multiple aspects of their lives, not just their 
feelings about their health. This means that other areas also matter, such as housing, 
employment and such non-traditional areas of government policy as friendships, autonomy 
and volunteering.  
The domains and measures will be further developed as the Measuring National Well-being 
Programme progresses, including to address subgroups, such as children.  
Work by OECD 
Work by OECD on measuring well-being represents a recent major effort by an international 
organization. The interest in new measures came out of the long-standing debate on how far 
traditional indicators, such as GDP per capita, actually measure well-being. Evidence from within 
the European Region and beyond suggests that one should look beyond markets, national averages 
and a focus on current economic well-being. OECD’s work also builds on other important 
initiatives in the field, such as the report by the Commission on the Measurement of Economic 
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Performance and Social Progress (61), set up by the French Government in 2008; the European 
Commission’s 2009 communication on measuring progress in a changing world (87) and 
subsequent work; the Group of 20 leaders’ statements from 2009, 2010 and 2011 (88); OECD 
ministerial council conclusions in 2010 (89) and national initiatives.  
The resulting OECD Better Life Initiative, described in its 2011 report How’s life? (90) and 
distributed through an interactive tool (the Your Better Life Index) covering OECD Member States, 
builds on almost 10 years of work. This framework (Fig. 74) has four distinctive features.  
• It focuses on people (individuals and households): both their individual attributes and how 
people relate to others in the community where they live and work.  
• It looks beyond the purely economic aspects of well-being (people’s command over resources 
and commodities), conceiving well-being as a truly multidimensional concept.  
• It considers the distribution of well-being in the population alongside average achievements 
of each country.  
• It considers both current and future well-being, assessing the latter in terms of key resources 
(observable today) that have the potential to generate well-being over time.  
Fig. 74. OECD framework for measuring well-being 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Measuring well-being and progress (91). 
Measurement of each domain is based on indicators, the criteria for which include unambiguous 
interpretation, amenability to policy changes and the possibility of disaggregation by population 
subgroups. The availability of high-quality data is also considered, normally from official statistics 
(with comparable definitions across countries). In addition, OECD integrated into its dashboard of 
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well-being indicator data from non-official sources such as Gallup. These are placeholders for 
indicators based on comparable official surveys that should become available in the future.  
Work by Gallup 
Since 2006, Gallup, a private company, has been conducting an international poll, which provides 
practical experience with collecting international data on well-being over time. The Gallup World 
Poll (92), primarily reflecting self-reported data, covers at least 130 countries in any given year, and 
asks about a wide range of topics, including health. Its well-being index combines objective and 
subjective measures, with self-reported health as one of five domains included as objective 
measures (Fig. 75).  
Fig. 75. Gallup model for measuring well-being through the World Poll 
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Source: Gallup World Poll (92).  
A recent OECD working paper (93) used Gallup World Poll data to explore the determinants of 
well-being and examine the drivers of measures of affect (positive and negative states), as well as 
the determinants of life satisfaction that are more prevalent in the existing literature. It reported that 
(93): 
Overall, items relating to health status, personal security, and freedom to choose what to do with one’s 
life appear to have a larger impact on affect balance when compared to life satisfaction, while 
economic factors such as income and unemployment have a more limited impact. … Relatively small 
differences are found between men and women, but priorities change significantly over the life course.  
Moreover, since 2008 Gallup has conducted a daily survey in the United States of America covering 
six domains, including emotional and physical health, which provides data on micro trends. This 
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tool has already collected information from over 1 million randomly selected respondents, and links 
emotional and physical health with micro information on basic access to health care, work 
environment and healthy behaviour. The project has expanded into Europe, to Germany and the 
United Kingdom, and will regularly provide information for public health programmes. The tool 
can be used to conduct assessments in communities and organizations and among health service 
providers.  
Collecting and reporting on data from a large number of countries around the world present serious 
methodological challenges. Drawing on its experience with estimating population preferences, 
Gallup is setting strict standards to ensure proper sampling, analysis and comparability across 
countries: a particular challenge for a private company, as public authorities frequently do not 
provide access to all facilities used by official statistical agencies conducting surveys or polls. 
Nevertheless, Gallup has also provided tools for individuals to track their well-being and is 
developing ways to collect biomarkers of individual well-being, such as taking saliva samples and 
providing analysis of stress levels.  
Work by WHO 
An effort to measure well-being at the global level is nested within the WHO Study on Global 
AGEing and Adult Health (SAGE) (94). SAGE is a worldwide survey of ageing and health, 
drawing on population-representative samples from six countries: China, Ghana, India, Mexico, the 
Russian Federation and South Africa. It has a total sample of around 45 000 people, with 
oversampling of people aged 50 years or more to provide more detailed information. The aim is to 
track changes in health and to have a clear, meaningful concept of well-being over time: a baseline 
cohort was set up in 2002–2004, and the first full wave was carried out in 2008–2010. Two further 
waves are or planned for 2013 and 2015. The survey looks at health conditions, functioning in daily 
life (self-reported health status and performance tests in a range of domains) and people’s subjective 
well-being.  
Within this framework, well-being is seen as made up of a combination of subjective appraisal 
(happiness, life satisfaction) and affective experience (Fig. 76). SAGE measures subjective well-
being through a combination of life satisfaction (using WHO Quality of Life (WHOQoL) 8: eight 
questions about satisfaction with different domains of life and life overall) and experienced well-
being through the Day Reconstruction Method (see 59).  
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Fig. 76. Overall SAGE measurement framework 
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Source: WHO Study on Global AGEing and Adult Health (SAGE) (94).  
The data collected allow analysis of various factors affecting changes in well-being over the life-
course. The results to date suggest that overall happiness and experienced well-being have very 
similar determinants: a strong relationship with health status, chronic disease and disability; and 
consistent relationships with age, income, education, social networks and the broader environment. 
In the future this study may help to improve understanding of well-being and its measurement by 
identifying biomarkers of well-being, examining framing effects within different methodologies 
(such as how the way questions are asked can influence the response), making comparisons 
between populations and identifying relations with characteristics such as temperament. Better ways 
of interpreting the data will bring stronger validity, leading to greater use of longitudinal survey 
data in identifying and evaluating possible interventions, and making policy (59).  
In the European Region, Finland, Poland and Spain are collecting similar data. 
Work by the United Nations 
A recent global report commissioned by the United Nations (95) starts with the premise that we 
need a very different model of humanity, one that does not put rising income or economic growth at 
the centre of what matters in life. The report is part of the response to a 2011 United Nations 
General Assembly resolution that invited Member States to “pursue the elaboration of additional 
measures that better capture the importance of the pursuit of happiness and well-being in 
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development with a view to guiding their public policies” (96). Similar to the origins of OECD 
work in this area, the aim is to learn from studies and existing data, even if not from official 
sources, that consistently show that higher average incomes do not necessarily improve average 
well-being within a country or across countries. This is not to discard the idea that higher household 
income (or higher GDP per capita) usually signifies an improvement in the life conditions of the 
poor. Instead, the report (95) argues that the information used to build an understanding of what 
makes lives better should include measures of subjective well-being.  
The report is not billed as addressing subjective well-being, but as the first World happiness report 
(95), reviewing and reporting on data collected by others, including the World Values Survey, the 
Gallup World Poll and several other national and international surveys, including the European 
Social Survey. It argues that the assessment of social progress needs a broader set of domains, 
which addresses both objective and subjective aspects of well-being. Moreover, information on 
multiple domains provides policy-makers with a greater understanding of the implications of their 
policies and decisions, beyond income or economic growth.  
The report (95) concedes that, for many: 
Happiness seems far too subjective, too vague, to serve as a touchstone for a nation’s goals, much less 
its policy content. That indeed has been the traditional view. Yet the evidence is changing this view 
rapidly. A generation of studies by psychologists, economists, pollsters, sociologists, and others has 
shown that happiness, though indeed a subjective experience, can be objectively measured, assessed, 
correlated with observable brain functions, and related to the characteristics of an individual and the 
society.  
External factors proposed as important domains or key determinants of subjective well-being are 
income, work, community and governance, and values and religion. Among the more personal 
factors are mental and physical health, family experience and education. Differences in the level of 
well-being by sex and age are also noted.  
The main message from the data across countries is that wealth is not the only thing that makes 
people happy, in terms of subjective well-being. In fact, political freedom, strong social networks 
and an absence of corruption are together more important than income in explaining differences in 
well-being between the highest- and lowest-ranking countries. Other things also matter: at the 
individual and household level, good mental and physical health, someone to count on, job security, 
stable families and community trust are crucial.  
Reporting and presenting data 
Well-being is multidimensional; this creates challenges for presenting data. Much can be learned 
from current efforts around the world, including those of OECD, when crafting an approach to 
communicate results across the European Region’s 53 Member States. Typical approaches to 
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presenting multidimensional concepts include using a dashboard or combining data into composite 
measures (reflecting composite indices); each has advantages and disadvantages.  
With dashboards, patterns are straightforward to interpret and require no specific assumptions. Such 
images, however, can sometimes make it difficult to understand the main message (Table 6), and 
priorities can be hard to set. In addition, taking the dashboard approach may lead to not being as 
parsimonious as possible with indicators.  
Table 6. Dashboard of OECD Better Life Index: multiple domains and countries 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. Circles denotes OECD countries in the top two deciles; diamonds, those in the bottom two deciles, and triangles, those in the six 
intermediate deciles. In addition, the indicator "Dwelling with basic facilities" considers only data referring to dwellings without indoor 
flushing toilet. 
Source: OECD calculations based on the indicators shown in How's life? Measuring well-being (90). 
Composite measures may be easier to communicate (especially for the public and policy-makers), 
and they can help to support priority setting. Their creation depends on assumptions (that are 
arbitrary, to some extent), however, and may lack transparency; they can also be overly simplistic in 
representing complex phenomena (Fig. 77).  
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Source: How's life? Measuring well-being (90).  
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 One solution is to use both approaches in a complementary way. Dashboards provide information 
on each component and are easier to interpret; composite indices can be used to show highlights and 
to assess interconnections between drivers of well-being, for example.  
Box 20. Discussion points – what we can build on? 
• Efforts to measure well-being at the population level are more relevant in practice than those focusing on 
specific clinical subpopulations.  
• Subjective well-being measures should be complemented by objective measures, even if self-reported.  
• In practice there is a high degree of cooperation between international organizations in this area and 
complementarities between international and national initiatives.  
• For policy-makers, the main issues are often external, environmental factors affecting well-being, since 
government policy might be able to influence these in a stable way in the long term.  
What are the challenges in measuring health and well-being? 
Despite general agreement on what makes a good life and the availability of multiple tools and 
approaches, researchers agree that the field of measuring well-being lacks clear definitions and 
rigorous assessment methods. There are several plausible reasons for this, including a narrow 
conceptualization of health and well-being, limited data sources and unclear application of 
information on well-being in the context of monitoring or improving health. In addition, the 
measures of health included in well-being indices often continue to measure mortality or illness 
(“ill-being”), not the positive end of what constitutes health and well-being.  
Another challenge may be the inability to choose from a range of potential measures of well-being; 
there are many and almost all ask different questions or include different existing data, such as from 
economic, social or health surveys or statistics. Yet another is that most efforts to measure the level 
of health in the context of well-being have been primarily based on subjective measures that might 
be perceived as difficult to compare over time, across countries or across socioeconomic groups. 
Without clear guidelines, another challenge is the interpretation of collected data: some approaches 
combine domains that are measured at the individual level and the community or national level. 
Such indices are difficult to interpret if some of the parts improve while others stagnate or worsen.  
Box 21. Key messages – challenges for measuring health and well-being 
• There is no single definition of well-being across place or time, yet all agree that health is a key component.  
• Multiple measurement approaches exist, with no criteria on how to select a tool.  
• Presentation of multidimensional data is not always consistent or transparent.  
• Interpretations can be limited because of differences in how domains are weighted or combined, and the 
difficulty of combining data on different scales.  
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A roadmap for advancing measurement of health and well-being 
Reflecting the recommendations of the expert group convened by the WHO Regional Office for 
Europe and the new Health 2020 policy (1,59,60), the WHO Regional Office for Europe is 
committed to providing operational clarity on how health is measured in the context of well-being. 
Recommendations and agreed criteria include the following steps.  
A definition of well-being that is conceptually sound should be developed. As far as possible, the 
operational approach should draw on models that have been used at the population level, such as the 
OECD Better Life Index. The choice of domains used to measure well-being should aim for 
maximum coherence with other approaches at the international level.  
For the health component of well-being, the range of domains and subsequent indicators tested 
should be linked to the International Classification of Functioning, Disability and Health (ICF) (97), 
WHO’s framework for measuring health and disability at both the individual and population levels. 
ICF is structured around the following broad components: 
• body functions and structure;  
• activities (related to tasks and actions by an individual) and participation (involvement in a 
life situation);  
• additional information on severity and environmental factors.  
It complements WHO’s International Classification of Diseases, which contains information on 
diagnosis and health condition, but not functional status. Moreover, at minimum, health in the 
context of well-being must include social, mental and physical health.  
Indicators selected to measure each aspect of the health domain need to be linked to an agreed 
target for monitoring progress towards the Health 2020 goal: to improve population health in the 
context of well-being. Approaches to measurement should be as objective as possible, although 
without discarding validated self-reported measures or lessons from assessments of health systems’ 
performance. This includes identifying measurement indicators where data already exist, or 
recommending potential new measures that need to be developed and tested. In either case, 
measurement of these indicators should reach acceptable levels of reliability and validity.  
The measurement approach should allow for the comparison and interpretation of health in the 
context of well-being within and across countries. Thus, values (data) for each indicator of health 
should be made available, and different potential approaches to combining the indicators and to 
reporting and interpreting a single index for the health domain should be tested and evaluated.  
How policy-makers, health professionals and other interested stakeholders across the WHO 
European Region can use this information should be documented and communicated. 
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Communication should also include tools that allow presentation and interaction in a web-based 
medium.  
Where are we now? 
Based on the expert technical consultations in 2012 (59,60), the WHO Regional Office for Europe 
proposes an initial high-level definition of well-being that could serve as an umbrella for other 
international population-based efforts: 
Well-being exists in two dimensions: subjective and objective. It comprises an individual’s experience 
of their life and a comparison of life circumstances with social norms and values.  
The term “social norms and values” is meant to capture the minimum threshold or level of different 
objective elements of well-being, recognizing such thresholds may change over time. Additional 
explanatory detail for the recommended definition includes the following.  
• Well-being and health are interactive, with some common determinants, such as health and 
social systems. Health influences overall well-being, yet well-being also predicts future 
health.  
• Across countries people usually agree on the big picture (the minimum ingredients of well-
being), even if identification of the important areas or components remains a normative 
exercise.  
• Subjective experiences can include a person’s overall sense of well-being and psychological 
functioning, as well as affective states. Examples of objective well-being and life 
circumstances include health, education, jobs, social relationships, environment (built and 
natural), security, civic engagement and governance, housing and leisure.  
This definition recognizes that multiple domains or areas cover different aspects of well-being, with 
health an important domain of and contributor to well-being. Fig. 78 illustrates these domains and 
contributors, and indicates the approaches or entry points for improvement. As discussed, refining 
the mapping of the processes and pathways towards the state of well-being will help to clarify the 
potential entry points for action to improve average well-being and its distribution within a 
population.  
Moreover, both subjective and objective elements could be incorporated as complementary parts of 
each domain of well-being. It is important, however, to clarify which framework will be used and 
for what purpose. For example, a descriptive framework would help to identify how to describe and 
measure well-being. An action-oriented framework would help policy-makers or practitioners 
understand the entry points for action and change, based on attribution studies and evidence on what 
works in practice.  
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Establishing how to refine the frameworks and move towards a specific definition of well-being in 
this context requires a more detailed review of the existing concepts. Although well-being clearly 
covers a range of domains, including health among many others, the expert group recommended 
that the Regional Office focus on its central mandate of health and concentrate advances in 
measurement on the areas of health and the health-related aspects of well-being (59,60).  
Testing hypothesized relationships with different illness and disease groups, different 
socioeconomic and demographic groups, and other external criteria in advance will strengthen the 
interpretation and usefulness of multidimensional profiles of health and well-being. For this specific 
area, given the lack of existing data (depending on the choices made about the definition and 
indicators of well-being to be used), one option would be to have at least one process target for 
Health 2020, on governments’ collecting data on well-being. This could be accompanied by a 
roadmap towards an outcome target, depending on the process target. This in turn could take 
account of inequities and variations within the Region by framing the outcome target in terms of 
reducing the gaps identified for specific groups at the national level. Other options include setting a 
target of increasing total well-being (however measured) within the Region; focusing on a few 
specific aspects (linked to health), or focusing on reducing inequalities in a particular dimension of 
overall well-being (such as reducing the social gradient related to income or education).  
How can this information be used to improve health and well-
being? 
Government policy-making is a process formed and developed over time. This can include setting 
high-level policy objectives, discussing the role of government in achieving them and identifying 
where and how governments can best use resources, including managing trade-offs and competing 
priorities. Policy-making often involves a wide range of actors, from government ministers and key 
decision-makers, other politicians and parliamentarians, special interest groups, patient and 
community groups, civil servants, public service professionals, researchers and other experts to 
members of the public.  
The past few years have witnessed national and international initiatives promoting policy use of 
well-being indicators that reach beyond measuring economic performance and can supplement 
standard metrics of mortality, disability or disease within the health sector. These initiatives vary in 
scope, methods, targets and key audiences. Some are briefly presented in this chapter. Some 
initiatives share the goal of involving citizens in the definition of measures of well-being and 
progress. Across many countries, activities to link well-being and health are increasing, including 
target setting to improve interventions addressing health in the context of well-being (Box 22). 
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While the direct relevance of these initiatives and their objectives to policy varies, they all aim at 
informing policy-making: for example, the OECD Better Life Index was launched to promote 
benchmarking and mutual learning (90).  
Box 22. Case study: occupational health and well-being in the former Yugoslav 
Republic of Macedonia 
The country’s Institute of Occupational Medicine, a WHO collaborating centre, promotes WHO principles in 
the field of occupational health, including well-being, at the national and international levels. The Institute 
took part in preparing the country’s national strategy and action plan for safety and health at work for 2011–
2015, coordinated by the Ministry of Health. This joint action resulted in the establishment of a national 
public health network of occupational health services, intended to improve health and well-being among 
vulnerable groups of workers.  
Since 2007 the Institute has implemented the new basic occupational health services approach, within the 
framework of preventive programmes to assess health status and work ability, to support agricultural workers 
and unemployed people. Some of the activities that evaluate interventions from the perspective of impact on 
workers’ well-being include research on workplace stress and burnout (supported by the EU’s Seventh 
Framework Programme), and on occupational risks of infectious disease among health workers.  
In addition, the Institute participated in the development of the national strategy and action plan to adapt 
health care to climate change (2011–2015), a heat–health action plan and an action plan on the prevention of 
adverse population health affects due to cold weather. The Institute also initiated the establishment of the 
South-eastern European Network on Workers’ Health, which also includes Albania, Bosnia and 
Herzegovina, Bulgaria, Croatia, Montenegro, Romania, Serbia, and Turkey. The Network’s purpose is to 
strengthen subregional cooperation in occupational health, contributing to the implementation of the WHO 
Global Plan of Action on Workers’ Health (98).  
Health 2020 aims to establish policy targets, which implies putting in place actions to improve the 
situation. For use within the Health 2020 framework, both the information content and the entry 
points of well-being measures need to be considered carefully. For example, in the case of health 
outcomes, some of the relevant drivers may pertain to the characteristics of individuals (patients), 
others to the programmes of service delivery and implementation (such as the health system), and 
still others to the environment where people live (including environmental and working conditions, 
immigration, income and other inequalities). Health systems clearly contribute to health and well-
being: lessons from assessments of health systems’ performance and related approaches to 
quantifying and attributing their overall contributions are crucial to ensuring the policy relevance of 
such efforts (Box 23).  
Although beyond the scope of this discussion, some of these factors may not be directly amenable 
to policy interventions, while other measures of societal progress (such as measures of social 
connections or subjective well-being) may be too general to identify a causal link to government 
interventions in specific fields.  
Box 23. Health systems’ contribution to well-being 
Health systems, health, wealth and societal well-being: assessing the case for investing in health systems 
(99), a publication by the European Observatory on Health Systems and Policies, describes health systems’ 
contributions to societal well-being in three main ways, based around a conceptual framework (see figure 
below).  
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• Health systems produce health, which is a major component of well-being.  
• Health systems promote wealth by being a significant component of the economy, which is an indirect yet 
key contributor to well-being.  
• Health systems directly affect societal well-being as people draw satisfaction from the existence of health 
services and their ability to access them.  
Health systems, health, wealth and societal well-being 
WealthHealth
Health systems
Social
well-being
 
The constellation formed by these three factors in enhancing societal well-being and the nature of the 
interrelationships between health systems, health and wealth  necessarily differ between contexts and 
jurisdictions or countries. Well-being is something of a general principle in this work (99), and health 
systems’ contribution is not explicitly measured. Rather, it outlines that better health outcomes and healthier 
populations, via well-functioning health systems, can contribute to greater societal well-being.  
Health is central to wealth and societal well-being (and health systems are a catalyst) 
Health constitutes a major component of well-being.  
• Health is valued in and of itself, and citizens in the European Region place a high value on good health.  
• Health increases economic productivity and national income, which can promote societal well-being 
(healthier people are more productive).  
Health has an impact on wealth and vice versa.  
• Health may contribute to budgetary gains from health expenditure savings (better health reduces demands 
on health care now and in the future).  
• Wealth affects health directly through material conditions, and indirectly though social participation and 
people’s control over their lives.  
Health also reflects the progress of societies, and measures of social development must include it.  
Investment in health systems brings real benefits 
Societies can choose how and how much to invest in health systems, despite competing demands for 
resources. Appropriate investment in health systems is an effective way of improving health and wealth, 
thereby contributing to societal well-being.  
• Health systems support healthier, more economically active societies.  
• Health services save lives.  
• Well-targeted public health interventions make a difference.  
• Health systems help to create societal well-being, not least by promoting equity and responsiveness.  
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The Observatory has a dedicated programme on health system performance assessment, whose objectives are 
to “improve approaches to measurement and analysis, and to demonstrate how comparative metrics can help 
in the design and evaluation of initiatives intended to strengthen health systems” (100). Health systems, 
health, wealth and societal well-being (99) documents progress in this area, with a second volume planned 
for 2013.  
Further, there are potential limitations to using well-being indicators. Many indicators used by 
organizations or Member States are better suited to monitoring well-being than evaluating the 
impact of specific policy measures. It is nevertheless important to take account of how the outcomes 
measured respond to policy interventions and how other organizations, such as OECD, have fine-
tuned the choice of indicators from a policy perspective.  
The WHO Regional Office for Europe can support the use of health and well-being measures in 
policy in the following ways. It can: 
• provide evidence on the mechanisms and tools that the health sector can use to enhance well-
being in all sectors; this role could be expanded to support policy-makers in improving well-
being within the health sector, in other sectors, across government and in partnership with 
nongovernmental actors; 
• disseminate policy-relevant information prepared in collaboration with European institutions 
or Member States (Box 24); 
• investigate how well-being indicators should be interpreted and used in connection with 
standard measures of mortality, morbidity and health system performance: well-being 
indicators are meant to complement, rather than replace, such measures.  
Box 24. Usefulness of well-being measures to policy-makers  
OECD analysis (90,101) indicates that policy-makers use well-being measures:  
• to stimulate public discourse and help policy-makers to focus on policies that matter to people’s lives – 
making more legitimate and socially acceptable policies that are more likely to succeed;  
• to identify priorities for action needed to achieve the overall goal of improving people’s lives; and 
• to offer a broad set of criteria against which specific policy interventions can be evaluated.  
Priorities emerge from defining what matters to well-being; identifying relative strengths and weaknesses in 
life conditions in a particular country, inequalities in well-being within countries and particularly vulnerable 
groups of people who may benefit from policy interventions; and assessing the interrelations between the 
different dimensions of well-being and their policy determinants, with a view to better managing trade-offs 
between them. 
A research agenda covering the statistical and methodological issues touched on in this chapter is 
warranted. It could also include ways to develop and test how best to communicate well-being 
measures that: 
• include health as an important domain;  
• connect this work to health system performance assessment;  
• provide a broader picture of what matters for a good life;  
• consider how changes in one domain can influence changes in another or multiple domains.  
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Moving forward 
Improving health and well-being is a recognized and essential component of Health 2020. A wide 
range of continuing activities measuring well-being at the international level in Europe, as well as 
many national initiatives (Box 25), provide a strong basis from which the WHO Regional Office for 
Europe can advance this work, particularly measuring health in the context of well-being.  
Box 25. Case study: child well-being in Italy – a wealth of research studies 
Italian indicators of child well-being are available, with those of 20 other countries, in a report by the United 
Nations Children’s Fund (UNICEF) on a project on child well-being in rich countries (see table).  
Summary table: child well-being in rich countries 
  Dimension 1  Dimension 2  Dimension 3  Dimension 4  Dimension 5  Dimension 6 
Dimensions 
of child 
well‐being 
Average 
ranking 
position  
(for all 6 
dimensions) 
Material 
well‐being 
Health and 
safety 
Educational 
well‐being 
Family and 
peer 
relationships 
Behaviours 
and risks 
Subjective 
well‐being 
Netherlands  4.2  10  2 6 3 3  1
Sweden  5.0  1  1 5 16 1  7
Denmark  7.2  4  4 8 9 6  12
Finland  7.5  3  3 4 17 7  11
Spain  8.0  12  6 16 8 5  2
Switzerland  8.8  6  9 14 4 12  6
Norway  8.7  2  8 11 10 13  8
Italy  10.0  14  5 20 1 10  10
Ireland  10.2  19  19 7 7 4  5
Belgium  10.7  7  16 1 5 19  16
Germany  11.2  13  11 10 13 11  9
Canada  11.8  6  13 2 18 17  15
Greece  11.8  16  18 16 11 8  3
Poland  12.3  21  15 3 14 2  19
Czech 
Republic 
12.5  11  10 9 19 9  17
France  13.0  9  7 18 12 14  18
Portugal  13.7  16  14 21 2 15  14
Austria  13.8  8  20 19 16 16  4
Hungary  14.6  20  17 13 6 18  13
United 
States  
18.0  17  21 12 20 20  –
United 
Kingdom 
18.2  18  12 17 21 21  20
Note. OECD countries with insufficient data to be included in the overview: Australia, Iceland, Japan, Luxembourg, Mexico, New 
Zealand, the Republic of Korea, Slovakia and Turkey. 
Source: Child poverty in perspective (102).  
In addition, several national studies evaluate factors included in the broad definition of well-being, although 
none had previously focused on collecting specific indicators on child well-being. The Italian National 
Institute of Statistics (ISTAT) started a survey in 2008 to evaluate functioning, disability, health and well-
being in students with disabilities in primary and lower secondary schools. Financed by the Ministry of 
Labour and Social Policy, in collaboration with the Ministry of Education, Universities and Research, its 
goal is to examine the resources and tools adopted by single school centres to facilitate the integration and 
inclusion of students with disabilities, and thus to improve their functioning and well-being. The survey 
provides indicators, based on the ICF framework (97), on types of health problem and the scholastic 
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environment: accessibility of buildings, presence of learning support teachers, presence of other specific 
professional figures and use of learning technologies.  
Two rounds have been completed (2008–2009 and 2009–2010), and the first-round results are available in 
English (103). For the second round, more than 89% of schools (over 23 000) completed the questionnaire. 
Analysis of the third round from 2012 is under way.  
A new publication provides another overview of Italian child poverty and well-being (104), and there are 
several ongoing research studies on child well-being in Italian universities and research centres, linking 
mental, physical and social functioning. The Foundation of the Carlo Besta Neurological Institute has also 
implemented pilot studies on disability, well-being and health-related quality of life in children with 
neurological disorders, such as Tourette’s syndrome and dystonia.  
Nevertheless, national efforts (within the health ministry, other ministries or national statistical 
agencies) or research studies to conceptualize, collect or use information on health and well-being 
are lacking in a large number of countries in the Region. Any effort to improve well-being at the 
regional level should consider options to support a broad range of countries, with different data and 
measurement starting points, connecting research centres with policy-makers in health and other 
sectors.  
This chapter outlines an approach to further develop the measurement of progress towards health in 
the context of well-being – what we value. Addressing the challenges identified across the 
European Region and achieving solutions by 2020 will require the identification of collaborators, 
resources and processes that can support joined-up work: marking progress. Some areas for this 
agenda are discussed in the last chapter of this report, including mechanisms to refine concepts and 
agree on norms, validity and limitations; methodological issues; measurement approaches and 
challenges; and interpretation of health and well-being at the level of the European Region. 
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4. Next steps in the countdown to 2020: marking progress 
While this report shows the wealth of health information available in the WHO European Region, 
considerable measurement challenges remain:  
• relevant data to measure progress are not available for all countries;  
• definitions vary between countries and disease classifications are not homogeneously applied; 
and  
• vital-event registration varies in population coverage and is not yet compulsory in all 
countries in the Region.  
The WHO Regional Office for Europe is committed to assisting Member States to enhance their 
progress in reporting and monitoring health information with the implementation of Health 2020.  
One of the major challenges to the implementation and impact of Health 2020 is the availability of 
data at the country level to monitor progress. The overarching targets and their indicators were 
selected for data availability, as well as their importance in achieving Health 2020. Information 
either routinely or regularly collected in most European countries can supply data on most 
indicators listed for the targets. Nevertheless, differences in definitions, population coverage and 
data quality hamper comparisons. As progress will be measured at the regional level, these 
difficulties will be multiplied, but limitations do not make comparisons meaningless.  
The Regional Office supports countries with tools and instruments to enhance the collection, 
analysis and reporting of health information at the country level. As mentioned, it is working with 
the European Commission and OECD to establish a single integrated health information system for 
Europe, covering all 53 Member States (Box 26).  
Box 26. Roadmap to an integrated health information system for Europe 
 
© Ministry of Health, Russian Federation                                        © WHO/Brian Cassar 
Since 2011, the European Commission and the WHO Regional Office for Europe have worked together to 
establish an integrated health information system for all 53 countries in the European Region. Initial steps 
already completed include: 
 analysis and mapping of all databases and data collections in both agencies;  
 establishment of new partnerships, including with OECD; and  
 150 
 
 the development of a roadmap to create a single platform for European health information. 
The next steps include detailed situation analyses for countries and a plan for the integration of key core 
indicators into the platform.  
This integrated system will in time reduce the reporting burden of countries, which often submit information 
to several agencies. It will also serve as one-stop-shop for health information in Europe.  
This work is well under way, as is the development of a health information strategy for the Region. During 
the 2012 session of the Regional Committee, the Regional Office and OECD signed a joint action plan that 
includes concrete collaboration in several areas of public health, including health information.  
Key challenges include: 
• addressing the range of data sources and norms/standards, from vital statistics to household 
surveys, so that these contain common ways to disaggregate data by social or other strata, 
and enable the monitoring of health inequalities within and across countries;  
• establishing how to allocate all 53 countries within meaningful subEuropean aggregations or 
subregional trends, since the current subregional groups (EU12, EU15 and CIS – see Annex 
1) do not include 14 Member States;  
• increasing the validity and reliability of data reported to the Health for All database (6) from 
across all 53 countries, in the light of collaborative work with Member States and other 
regional entities;  
• improving the measurement and reporting of the overall burden of disease, including 
morbidity and other conditions particularly addressing mental health;  
• collecting, linking and making accessible data across health and other sectors, to support the 
health-in-all-policies approach and intersectoral analysis, policy-making, monitoring and 
evaluation;  
• making progress on surveillance and outbreak monitoring, as well as compliance with the 
International Health Regulations (105), across the European Region and via connections 
with other regions (through governance for health and tackling communicable diseases);  
• developing a road map to address these challenges and achieve solutions, identifying 
collaborators, resources and processes, and a research agenda to support joined-up action.  
Chapter 1 provides a detailed account of the health status of European populations. The indicators 
shown, however, are largely those describing mortality rather than summary measures of population 
health (such as DALYs). The latter combine information on fatal and non-fatal outcomes, providing 
a more comprehensive picture of the burden of disease. The Regional Office aims to work more 
closely with Member States to enhance the use of such summary measures, which include elements 
of disability and morbidity in addition to mortality.  
The increasing inequalities in health described in this report add urgency to the need to obtain a 
better understanding of the pathways to health and well-being and their distribution across the 
European Region and within countries. This will also include the ability to better attribute the share 
and degree of impact of an intervention on health (from within the health sector and from other 
sectors), and the associated reduction in health inequalities.  
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A major challenge is measuring well-being in the context of health and eventually setting a target 
level for it. As Chapter 3 outlines, many actors have tackled these questions in an intersectoral 
sense, and WHO is working with its partners to resolve this in the context of health. Chapter 3 also 
provides a detailed roadmap that will culminate in proposed indicators for well-being in 2013.  
Reducing the fragmentation and increasing the sustainability of health information systems across 
Europe are additional challenges. The expert meeting on indicators convened by the Regional 
Office in June 2012 (60) identified several different initiatives carried out over the years, 
particularly in the EU, to harmonize definitions, methods and collection of indicators, including the 
European Community Health Indicators (58), the WHO Environment and Health Information 
System (106) and the European Health Examination Survey (107). Financial constraints threaten 
many of these data collection efforts. Working closely with the European Commission, the 
Regional Office will support approaches to build on existing infrastructures and work towards a 
single integrated European health information system.  
The experts convened by the WHO Regional Office for Europe (60) made some key comments and 
recommendations to support this approach that the Regional Office, Member States and key 
partners could take forward. 
• Build on existing and ongoing health information activities. Several long-term health 
information activities, particularly at the EU level, are unfortunately being terminated. These 
activities have produced useful tools, methods and standards; they should not be discarded 
but put to further use.  
• Share knowledge and expertise with countries that are lagging behind: for example, 
knowledge on conducting surveys is lacking in some eastern European countries. Extra 
efforts are needed to increase the participation of countries from all parts of the European 
Region.  
• Emphasize the benefits of a common health information system that will reduce the 
administrative burden for Member States and improve data quality and interpretation.  
As part of work to support improved monitoring and reporting, the WHO Regional Office for 
Europe will encourage Member States to share their experience in working towards each of the 
Health 2020 targets, including best practices and success stories, and how methods and approaches 
worked in particular contexts.  
In addition, the Regional Office works with Member States and partners to enhance the use of new 
technologies and innovations, particularly in the area of e-health. Secure and relevant information 
exchange within the European context needs to be supported, while staying in line with data-
protection laws, patients’ rights and accountability.  
Information and evidence are only as good as their use by policy-makers. The Regional Office 
supports new initiatives to translate evidence into policy, including EVIPNet, the WHO Evidence-
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Informed Policy Network (108). This platform, which has been successful in other WHO regions, 
provides workshops and tools for countries to formulate, address and resolve policy questions using 
the best available evidence. The Regional Office officially launched EVIPNet Europe with four 
Member States in the central Asia in October 2012; it has received much support from participants 
and partners, including various United Nations organizations and donor agencies (108).  
© WHO  
 
 
 
 
 
 
 
 
 
 
The WHO Regional Office for Europe will complete its work to develop indicators for the Health 
2020 targets, including well-being, over the coming months through its expert groups and in close 
collaboration with Member States. A web-based country consultation and detailed discussions with 
governing bodies will precede the submission of final proposals to the Regional Committee in 
September 2013.  
The European health report 2012 is only the starting point of a journey that Member States in the 
European Region will take. It provides a platform for discussion and a basis for accountability and 
measurement of progress in implementing Health 2020 in the Region. The European health report 
2012 facilitates tracking of the impact of Health 2020 on health and well-being in Europe; future 
reports will use it as a baseline to measure success.   
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Annex 1. Technical notes for the demographic and epidemiological profile 
Data sources and methods 
Data sources for this report include demographic data from the United Nations World Population 
Prospects (2008 revision) and World Urbanization Prospects (2009 revision), and health-related 
data from the WHO European Health for All (January 2012 revision) and GLOBOCAN (2008) 
databases and from The global burden of disease: 2004 update (1–5).  
The main source is the European Health for All database (3), which contains over 600 indicators 
from demographic, socioeconomic, mortality, morbidity and hospital discharge, lifestyle, 
environment, health care resources, health care utilization and expenditure, and maternal and child 
health categories, disaggregated by sex and age groups, where pertinent. Time series for some 
indicators span 1970 to 2011, but most data used extend from 1980/1990 to 2009/2010. Although 
the number of countries in the WHO European Region nearly doubled after 1990, the statistics used 
represent data annually reported by today’s 53 Member States to the WHO Regional Office for 
Europe, contributing to its health monitoring efforts.  
European regional averages represent population-weighted averages, weighted by total population, 
population younger or older than 65 years, or number of live births – either for both sexes or solely 
for males or females, as appropriate. In most cases, mortality indicators represent the age- and sex-
standardized mortality rate, calculated with the direct method using the European standard 
population (3). Some of the estimates and projections used were produced by WHO, the 
International Agency for Research on Cancer (IARC) and the United Nations Population Division.  
The global burden of disease: 2004 update (5) divides the countries in the European Region into 
two groups: 
• high-income countries: Andorra, Austria, Belgium, Cyprus, Denmark, Finland, France, 
Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, Malta, Monaco, the 
Netherlands, Norway, Portugal, San Marino, Slovenia, Spain, Sweden, Switzerland and the 
United Kingdom;  
• low- and middle-income countries: Albania, Armenia, Azerbaijan, Belarus, Bosnia and 
Herzegovina, Bulgaria, Croatia, the Czech Republic, Estonia, Georgia, Hungary, 
Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Poland, the Republic of Moldova, Romania, the 
Russian Federation, Serbia and Montenegro (one country in 2004), Slovakia, Tajikistan, the 
former Yugoslav Republic of Macedonia, Turkey, Turkmenistan, Ukraine and Uzbekistan.  
In contrast, Chapter 2 of this report illustrates target development using historical country 
subgroups, as used in the European Health for All database (3):  
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• EU15: the 15 Member States belonging to the EU before 1 May 2004 – Austria, Belgium, 
Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, the Netherlands, 
Portugal, Spain, Sweden and the United Kingdom;  
• EU12: the 12 new Member States joining the EU in May 2004 or in January 2007 – Bulgaria, 
Cyprus, the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Romania, 
Slovakia and Slovenia; and  
• CIS (Commonwealth of Independent States until 2006): Armenia, Azerbaijan, Belarus, 
Georgia, Kazakhstan, Kyrgyzstan, the Republic of Moldova, the Russian Federation, 
Tajikistan, Turkmenistan, Ukraine and Uzbekistan.  
Countries in the European Region but not included in these groups are: Albania, Andorra, Bosnia 
and Herzegovina, Croatia, Iceland, Israel, Monaco, Montenegro, Norway, San Marino, Serbia, 
Switzerland, the former Yugoslav Republic of Macedonia and Turkey. 
A challenge identified in this report is how to allocate all 53 countries to meaningful sub-European 
aggregations, for example, to illustrate subregional trends in a contemporary context.  
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Like its predecessors, the 2012 European health report describes both the overall improvements in 
health in the WHO European Region and their uneven distribution within and between countries. It 
breaks new ground, however, by helping both to define well-being, a goal of Europe’s new health 
policy, and to map the way towards achieving it. 
The report shows that, while decreases in certain causes of death and advances in tackling risk 
factors and socioeconomic and living conditions have led to better health, health inequalities and 
their determinants occur – and in some cases are widening – in many parts of the Region. Avoidable 
inequalities that can be addressed by current knowledge are in fact health inequities. In response to 
this situation, the countries in the Region adopted the new European health policy, Health 2020, in 
2012; its aim is to improve the health and well-being of populations, reduce health inequities and 
ensure sustainable people-centred health systems. 
By describing health in Europe, this report provides policy-makers and public health professionals 
with the epidemiological evidence base that underpins Health 2020 and its six overarching targets. 
Further, it works to incorporate well-being in Health 2020 by quantifying a European target and 
relevant indicators. The report describes the WHO Regional Office for Europe’s work with partners 
and experts to develop a common concept and approach to well-being that both allow for valid 
measurement and yield information useful to policy-makers and in programme evaluation. It sets 
out the agreed approach to monitoring progress towards Health 2020, outlines the collaborative 
agenda to address the challenges ahead and makes the case for measuring well-being as a marker of 
progress in health. 
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Investing in health and health systems is especially important during 
times of crisis, such as the severe economic crisis and pandemic (H1N1) 
2009 influenza. To address these issues, governments and policy-makers 
need information that is current, accurate, comparable and user-friendly. 
What were the trends in public health indicators over the last four 
years? What faactors influence health, and what are the challenges for 
the future? What contribution can health systems make to improve 
population health in the WHO European Region? In addressing these 
questions, this report illustrates the wide-ranging reforms countries have 
undertaken to strengthen performance in four core functions of health 
systems: service delivery, resource generation, financing and stewardship. 
This report presents essential public health information to support 
countries in choosing sound investments in health. It should encourage 
the successful implementation of effective health system reforms and 
policies, and help countries improve their health systems’ performance 
to provide efficient, patient-centred, high-quality health care. The annex 
provides some of the data used in the analysis.
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